Epidermotropic cutaneous B-cell lymphoma mimicking mycosis fungoides
Chui, C. T., Hoppe, R. T., Kohler, S., & Kim, Y. H. (1999). Epidermotropic cutaneous B-cell lymphoma mimicking mycosis fungoides. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 41(2), 271–74.

What is the significance of nasal involvement in nasopharyngeal carcinoma?
Lin, Z. X., Li, D. R., Chen, Z. J., Zheng, M. Z., Shi, Y. Y., Lin, B. H., … Hoppe, R. T. (1999). What is the significance of nasal involvement in nasopharyngeal carcinoma? INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 45(4), 907–14.

The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.
Donaldson, S. S., Hancock, S. L., & Hoppe, R. T. (1999). The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects. Cancer Journal from Scientific American, 5(6), 325–33.

Management of breast cancer after Hodgkin's disease
Wolden, S. L., Hancock, S. L., Carlson, R. W., Goffinet, D. R., Jeffrey, S. S., & Hoppe, R. T. (2000). Management of breast cancer after Hodgkin's disease. JOURNAL OF CLINICAL ONCOLOGY, 18(4), 765–72.

Assessment of the Stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group Pilot Study E1492
Horning, S. J., Wiliams, J., Bartlett, N. L., Bennett, J. M., Hoppe, R. T., Neuberg, D., & Cassileth, P. (2000). Assessment of the Stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group Pilot Study E1492. JOURNAL OF CLINICAL ONCOLOGY, 18(5), 972–80.

Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease.
Hancock, & HOPPE. (1996). Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease. Seminars in Radiation Oncology, 6(3), 225–42.

Over 20 Years of Progress in Radiation Oncology: Hodgkin's Disease.
Smitt, M. C., Buzydlowski, J., & Hoppe, R. T. (1997). Over 20 Years of Progress in Radiation Oncology: Hodgkin's Disease. Seminars in Radiation Oncology, 7(2), 127–134.

Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic tell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma
Johnston, L. J., Stockerl-Goldstein, K. E., Hu, W. W., Negrin, R. S., Hoppe, R. T., Blume, K. G., & Horning, S. J. (2000). Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic tell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 6(5A), 555–562.

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial
Horning, S. J., Negrin, R. S., Hoppe, R. T., Rosenberg, S. A., Chao, N. J., Long, G. D., … Blume, K. G. (2001). High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial. BLOOD, 97(2), 404–9.

Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides
de Coninck, E. C., Kim, Y. H., Varghese, A., & Hoppe, R. T. (2001). Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides. JOURNAL OF CLINICAL ONCOLOGY, 19(3), 779–84.

Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University
Murtha, A. D., Knox, S. J., Hoppe, R. T., Rupnow, B. A., & Hanson, J. (2001). Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 49(1), 3–15.

Natural killer/natural killer-like T-Cell lymphoma, CD56+, presenting in the skin: An increasingly recognized entity with an aggressive course
Mraz-Gernhard, S., Natkunam, Y., Hoppe, R. T., Leboit, P., Kohler, S., & Kim, Y. H. (2001). Natural killer/natural killer-like T-Cell lymphoma, CD56+, presenting in the skin: An increasingly recognized entity with an aggressive course. JOURNAL OF CLINICAL ONCOLOGY, 19(8), 2179–88.

High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: The Stanford University experience
Cao, T. M., Horning, S. F., Negrin, R. S., Hu, W. W., Johnston, L. F., Taylor, T. L., … Stockerl-Goldstein, K. (2001). High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: The Stanford University experience. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 7(5), 294–301.

NCCN: Non-Hodgkin's lymphoma.
Zelenetz, A. D., & Hoppe, R. T. (2001). NCCN: Non-Hodgkin's lymphoma. Cancer Control , 8(6), 102–113.

Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: Mature results of a prospective clinical trial
Horning, S. J., Hoppe, R. T., Breslin, S., Bartlett, N. L., Brown, B. W., & Rosenberg, S. A. (2002). Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: Mature results of a prospective clinical trial. JOURNAL OF CLINICAL ONCOLOGY, 20(3), 630–37.

Primary radiotherapy for localized orbital malt lymphoma
Le, Q. T., Eulau, S. M., George, T. I., Hildebrand, R., Warnke, R. A., Donaldson, S. S., & Hoppe, R. T. (2002). Primary radiotherapy for localized orbital malt lymphoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 52(3), 657–63.

Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation
Millan, T. L. T., Shizuru, J. A., Hoffmann, P., Dejbakhsh-Jones, S., Scandling, J. D., GRUMET, F. C., … Strober, S. (2002). Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. TRANSPLANTATION, 73(9), 1386–91.

Long-term follow-up after total lymphoid irradiation in pediatric heart transplant recipients
Chin, C., Hunt, S., Robbins, R., Hoppe, R., Reitz, B., & Bernstein, D. (2002). Long-term follow-up after total lymphoid irradiation in pediatric heart transplant recipients. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 21(6), 667–73.

Hodgkin's disease: A model for interdisciplinary cancer management: 2002 Janeway Lecture
Hoppe, R. T. (2002). Hodgkin's disease: A model for interdisciplinary cancer management: 2002 Janeway Lecture. CANCER JOURNAL, 8(6), 425–31.

Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial
Ekstrand, B. C., Lucas, J. B., Horwitz, S. M., Fan, Z., Breslin, S., Hoppe, R. T., … Horning, S. J. (2003). Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial. BLOOD, 101(11), 4285–89.

Topical nitrogen mustard in the management of mycosis fungoides - Update of the Stanford experience
Kim, Y. H., Martinez, G., Varghese, A., & Hoppe, R. T. (2003). Topical nitrogen mustard in the management of mycosis fungoides - Update of the Stanford experience. ARCHIVES OF DERMATOLOGY, 139(2), 165–73.

Gene expression profiles of cutaneous B cell lymphoma
Storz, M. N., van de Rijn, M., Kim, Y. H., Mraz-Gernhard, S., Hoppe, R. T., & Kohler, S. (2003). Gene expression profiles of cutaneous B cell lymphoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 120(5), 865–70.

Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome - Clinical prognostic factors and risk for disease progression
Kim, Y. H., Liu, H. L., Mraz-Gernhard, S., Varghese, A., & Hoppe, R. T. (2003). Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome - Clinical prognostic factors and risk for disease progression. ARCHIVES OF DERMATOLOGY, 139(7), 857–66.

THE MANAGEMENT OF HODGKINS-DISEASE IN RELAPSE AFTER PRIMARY RADIATION-THERAPY
Hoppe, R. T. (1992). THE MANAGEMENT OF HODGKINS-DISEASE IN RELAPSE AFTER PRIMARY RADIATION-THERAPY. EUROPEAN JOURNAL OF CANCER, 28A(11), 1920–1922.

SECONDARY LEUKEMIA AND MYELODYSPLASTIC SYNDROME AFTER TREATMENT FOR HODGKINS-DISEASE
Hoppe, R. T. (1992). SECONDARY LEUKEMIA AND MYELODYSPLASTIC SYNDROME AFTER TREATMENT FOR HODGKINS-DISEASE. Presented at the 2ND INTERNATIONAL COURSE - LEUKEMIA 1992 : RECENT PROGRESS IN BIOLOGY AND CLINICAL RESEARCH IN ADULT LEUKEMIA, GENOA,ITALY: NATURE PUBLISHING GROUP.

THE STANFORD EXPERIENCE WITH COMBINED PROCARBAZINE, ALKERAN AND VINBLASTINE (PAVE) AND RADIOTHERAPY FOR LOCALLY EXTENSIVE AND ADVANCED STAGE HODGKINS-DISEASE
Horning, S. J., Ang, P. T., Hoppe, R. T., & Rosenberg, S. A. (1992). THE STANFORD EXPERIENCE WITH COMBINED PROCARBAZINE, ALKERAN AND VINBLASTINE (PAVE) AND RADIOTHERAPY FOR LOCALLY EXTENSIVE AND ADVANCED STAGE HODGKINS-DISEASE. ANNALS OF ONCOLOGY, 3(9), 747–754.

CD30(+) cutaneous lymphoproliferative disorders: The Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma
Liu, H. L., Hoppe, R. T., Kohler, S., Harvell, J. D., Reddy, S., & Kim, Y. H. (2003). CD30(+) cutaneous lymphoproliferative disorders: The Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 49(6), 1049–58.

Mycosis fungoides: radiation therapy.
Hoppe, R. T. (2003). Mycosis fungoides: radiation therapy. Dermatologic Therapy, 16(4), 347–54.

COMBINED-MODALITY THERAPY FOR THE TREATMENT OF HODGKINS-DISEASE
Hoppe, R. T. (1992). COMBINED-MODALITY THERAPY FOR THE TREATMENT OF HODGKINS-DISEASE. Presented at the 26TH ANNUAL SAN FRANCISCO CANCER SYMP, SAN FRANCISCO,CA: KARGER.

Extranodal nonorbital indolent lymphomas of the head and neck: Relationship between tumor control and radiotherapy
MacDermed, D., Thurber, L., George, T. I., Hoppe, R. T., & Le, Q. T. (2004). Extranodal nonorbital indolent lymphomas of the head and neck: Relationship between tumor control and radiotherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. SALT LAKE CITY,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT,UT: ELSEVIER SCIENCE INC.

Short tandem repeat analysis to monitor chimerism in Macaca fascicularis
Lau, M., Vayntrub, T., GRUMET, F. C., Lowsky, R., Strober, S., Hoppe, R., … Borie, D. (2004). Short tandem repeat analysis to monitor chimerism in Macaca fascicularis. AMERICAN JOURNAL OF TRANSPLANTATION, 4(9), 1543–48.

Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients
Beynet, D. P., Wee, S. A., Horwitz, S. S., Kohler, S., Horning, S., Hoppe, R., & Kim, Y. H. (2004). Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients. ARCHIVES OF DERMATOLOGY, 140(9), 1140–46.

Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study
Sundram, U., Kim, Y., Mraz-Gernhard, S., Hoppe, R., Natkunam, Y., & Kohler, S. (2005). Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study. JOURNAL OF CUTANEOUS PATHOLOGY, 32(3), 227–34.

A technique of bone marrow collection from vertebral bodies of cynomolgus macaques for transplant studies
Flores, M. G., Holm, B., Larson, M. J., Lau, M. K., Si, M. S., Lowsky, R., … Borie, D. C. (2005). A technique of bone marrow collection from vertebral bodies of cynomolgus macaques for transplant studies. JOURNAL OF SURGICAL RESEARCH, 124(2), 280–88.

Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long-term survivors of Hodgkin's disease: July 9-16, 2003, Bellagio, Italy
Mauch, P., Ng, A., Aleman, B., Carde, P., Constine, L., Diehl, V., … Yahalom, J. (2005). Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long-term survivors of Hodgkin's disease: July 9-16, 2003, Bellagio, Italy. Presented at the 6th International Symposium on Hodgkins Disease, COLOGNE,GERMANY,GERMANY,GERMANY,GERMANY: WILEY-BLACKWELL.

Protective conditioning for acute graft-versus-host disease
Lowsky, R., Takahashi, T., Liu, Y. P., Dejbakhsh-Jones, S., GRUMET, F. C., Shizuru, J. A., … Strober, S. (2005). Protective conditioning for acute graft-versus-host disease. NEW ENGLAND JOURNAL OF MEDICINE, 353(13), 1321–31.

Staging accuracy in mycosis fungoides and Sezary syndrome using integrated positron emission tomography and computed tomography
Tsai, E. Y., Taur, A., Espinosa, L., Quon, A., Johnson, D., Dick, S., … Kim, Y. H. (2006). Staging accuracy in mycosis fungoides and Sezary syndrome using integrated positron emission tomography and computed tomography. ARCHIVES OF DERMATOLOGY, 142(5), 577–84.

LEU-8/CD7 ANTIGEN EXPRESSION BY CD3+ T-CELLS - COMPARATIVE-ANALYSIS OF SKIN AND BLOOD IN MYCOSIS-FUNGOIDES SEZARY-SYNDROME RELATIVE TO NORMAL BLOOD VALUES
Wood, G. S., Hong, S. R., Sasaki, D. T., Abel, E. A., Hoppe, R. T., Warnke, R. A., & Morhenn, V. B. (1990). LEU-8/CD7 ANTIGEN EXPRESSION BY CD3+ T-CELLS - COMPARATIVE-ANALYSIS OF SKIN AND BLOOD IN MYCOSIS-FUNGOIDES SEZARY-SYNDROME RELATIVE TO NORMAL BLOOD VALUES. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 22(4), 602–607.

THE MANAGEMENT OF MYCOSIS-FUNGOIDES AT STANFORD - STANDARD AND INNOVATIVE TREATMENT PROGRAMS
Hoppe, R. T. (1991). THE MANAGEMENT OF MYCOSIS-FUNGOIDES AT STANFORD - STANDARD AND INNOVATIVE TREATMENT PROGRAMS. Presented at the 2ND VICENZA INTERNATIONAL WORKSHOP OF HEMATOLOGY : NEW INSIGHTS IN LYMPHOMAS, VICENZE,ITALY: STOCKTON PRESS.

Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease
Heidenreich, P. A., Schnittger, I., Strauss, H. W., Vagelos, R. H., Lee, B. K., Mariscal, C. S., … Hancock, S. L. (2007). Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. JOURNAL OF CLINICAL ONCOLOGY, 25(1), 43–49.

METASTATIC CARCINOMA IN LYMPH-NODES SIMULATING SYNCYTIAL VARIANT OF NODULAR SCLEROSING HODGKINS-DISEASE
Bacchi, C. E., Dorfman, R. F., Hoppe, R. T., Chan, J. K. C., & Warnke, R. A. (1991). METASTATIC CARCINOMA IN LYMPH-NODES SIMULATING SYNCYTIAL VARIANT OF NODULAR SCLEROSING HODGKINS-DISEASE. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 96(5), 589–593.

Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome - Evidence from population-based and clinical cohorts
Huang, K. P., Weinstock, M. A., Clarke, C. A., McMillan, A., Hoppe, R. T., & Kim, Y. H. (2007). Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome - Evidence from population-based and clinical cohorts. ARCHIVES OF DERMATOLOGY, 143(1), 45–50.

Revised response criteria for malignant lymphoma
Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., … Diehl, V. (2007). Revised response criteria for malignant lymphoma. JOURNAL OF CLINICAL ONCOLOGY, 25(5), 579–586.

TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)
Kim, Y. H., Willemze, R., Pimpinelli, N., Whittaker, S., Olsens, E. A., Ranki, A., … Hoppe, R. T. (2007). TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). BLOOD, 110(2), 479–84.

Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease
Advani, R., Maeda, L., Lavori, P., Quon, A., Hoppe, R., Breslin, S., … Horning, S. J. (2007). Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease. JOURNAL OF CLINICAL ONCOLOGY, 25(25), 3902–7.

Hodgkin's lymphoma: The role of radiation in the modern combined strategies of treatment
Hoppe, R. T. (2007). Hodgkin's lymphoma: The role of radiation in the modern combined strategies of treatment. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 21(5), 915-?

Tolerance and chimerism after renal and hematopoietic-cell transplantation.
Scandling, J. D., Busque, S., Dejbakhsh-Jones, S., Benike, C., Millan, M. T., Shizuru, J. A., … Strober, S. (2008). Tolerance and chimerism after renal and hematopoietic-cell transplantation. New England Journal of Medicine, 358(4), 362–68.

Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma
Xie, X., Sundram, U., Natkunam, Y., Kohler, S., Hoppe, R. T., Kim, Y. H., … Hsi, E. D. (2008). Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma. MODERN PATHOLOGY, 21(6), 653–59.

Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease
Lee, J., Viakhireva, N., Cesca, C., Lee, P., Kohler, S., Hoppe, R. I., & Kim, Y. H. (2008). Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 59(4), 706–12.

Hodgkin disease/lymphoma.
Hoppe, R. T., Advani, R. H., Ambinder, R. F., Bierman, P. J., Bloomfield, C. D., Blum, K., … Zelenetz, A. D. (2008). Hodgkin disease/lymphoma. Journal of the National Comprehensive Cancer Network , 6(6), 594–622.

Indolent primary cutaneous B-cell lymphoma: Experience using systemic rituximab
Morales, A. V., Advani, R., Horwitz, S. M., Riaz, N., Reddy, S., Hoppe, R. T., & Kim, Y. H. (2008). Indolent primary cutaneous B-cell lymphoma: Experience using systemic rituximab. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 59(6), 953–57.

Low Stage Follicular Lymphoma: Biologic and Clinical Characterization According to Nodal or Extranodal Primary Origin
Weinberg, O. K., Ma, L., Seo, K., Beck, A. H., Pai, R. K., Morales, A., … Arber, D. A. (2009). Low Stage Follicular Lymphoma: Biologic and Clinical Characterization According to Nodal or Extranodal Primary Origin. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 33(4), 591–98.

TOTAL SKIN ELECTRON-BEAM THERAPY IN THE MANAGEMENT OF MYCOSIS-FUNGOIDES
Hoppe, R. T. (1991). TOTAL SKIN ELECTRON-BEAM THERAPY IN THE MANAGEMENT OF MYCOSIS-FUNGOIDES. Presented at the 25TH ANNUAL SAN FRANCISCO CANCER SYMP : THE ROLE OF HIGH ENERGY ELECTRONS IN THE TREATMENT OF CANCER, SAN FRANCISCO,CA: KARGER.

TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors
Kohrt, H. E., Turnbull, B. B., Heydari, K., Shizuru, J. A., Laport, G. G., Miklos, D. B., … Lowsky, R. (2009). TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. BLOOD, 114(5), 1099–1109.

Cutaneous Peripheral T-Cell Lymphoma Associated With a Proliferation of B Cells
Mattoch, I. W., Fulton, R., Kim, Y., Hoppe, R., Warnke, R. A., & Sundram, U. N. (2009). Cutaneous Peripheral T-Cell Lymphoma Associated With a Proliferation of B Cells. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 131(6), 810–19.

Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma Characterization of Clinical Subset With Worse Outcome
Woo, D. K., Jones, C. R., Vanoli-Storz, M. N., Kohler, S., Reddy, S., Advani, R., … Kim, Y. H. (2009). Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma Characterization of Clinical Subset With Worse Outcome. ARCHIVES OF DERMATOLOGY, 145(6), 667–74.

A Meta-analysis of Patients Receiving Allogeneic or Autologous Hematopoietic Stem Cell Transplant in Mycosis Fungoides and Sezary Syndrome
Wu, P. A., Kim, Y. H., Lavori, P. W., Hoppe, R. T., & Stockerl-Goldstein, K. E. (2009). A Meta-analysis of Patients Receiving Allogeneic or Autologous Hematopoietic Stem Cell Transplant in Mycosis Fungoides and Sezary Syndrome. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 15(8), 982–90.

OBSERVATIONS ON THE EFFECT OF CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY IN PATIENTS WITH MYCOSIS-FUNGOIDES
Knox, S. J., Levy, R., Hodgkinson, S., Bell, R., Brown, S., Wood, G. S., … Reichert, T. (1991). OBSERVATIONS ON THE EFFECT OF CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY IN PATIENTS WITH MYCOSIS-FUNGOIDES. BLOOD, 77(1), 20–30.

Dynamic CD8 T-Cell Responses to Tumor-Associated Epstein-Barr Virus Antigens in Patients With Epstein-Barr Virus-Negative Hodgkin's Disease
Kohrt, H., Johannsen, A., Hoppe, R., Horning, S. J., Rosenberg, S. A., Advani, R., & Lee, P. P. (2009). Dynamic CD8 T-Cell Responses to Tumor-Associated Epstein-Barr Virus Antigens in Patients With Epstein-Barr Virus-Negative Hodgkin's Disease. ONCOLOGY RESEARCH, 18(5-6), 287–92.

TOTAL LYMPHOID IRRADIATION FOR TREATMENT OF INTRACTABLE CARDIAC ALLOGRAFT-REJECTION
Hunt, S. A., Strober, S., Hoppe, R. T., & Stinson, E. B. (1991). TOTAL LYMPHOID IRRADIATION FOR TREATMENT OF INTRACTABLE CARDIAC ALLOGRAFT-REJECTION. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 10(2), 211–16.

THE STANFORD EXPERIENCE WITH HIGH-DOSE ETOPOSIDE CYTOREDUCTIVE REGIMENS AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA - PRELIMINARY DATA
Horning, S. J., Chao, N. J., Negrin, R. S., Hoppe, R. T., Kwak, L. W., Long, G. D., … Blume, K. G. (1991). THE STANFORD EXPERIENCE WITH HIGH-DOSE ETOPOSIDE CYTOREDUCTIVE REGIMENS AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA - PRELIMINARY DATA. ANNALS OF ONCOLOGY, 2, 47–50.

In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Brody, J. D., Ai, W. Z., Czerwinski, D. K., Torchia, J. A., Levy, M., Advani, R. H., … Levy, R. (2010). In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study. JOURNAL OF CLINICAL ONCOLOGY, 28(28), 4324–32.

STAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS USEFUL? THE STANFORD EXPERIENCE
Advani, R. H., Hoppe, R. T., Maeda, L. S., Baer, D. M., Mason, J., Rosenberg, S. A., & Horning, S. J. (2011). STAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS USEFUL? THE STANFORD EXPERIENCE. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(5), 1374–79.

Bone marrow transplantation for hematologic malignancies: the Stanford experience.
Chao, N. J., Amylon, M. D., Long, G. D., Negrin, R. S., Hoppe, R. T., Horning, S. J., & Blume, K. G. (1990). Bone marrow transplantation for hematologic malignancies: the Stanford experience. Clinical Transplants, 157–163.

REVISITING LOW-DOSE TOTAL SKIN ELECTRON BEAM THERAPY IN MYCOSIS FUNGOIDES
Harrison, C., Young, J., Navi, D., Riaz, N., Lingala, B., Kim, Y., & Hoppe, R. (2011). REVISITING LOW-DOSE TOTAL SKIN ELECTRON BEAM THERAPY IN MYCOSIS FUNGOIDES. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(4), E651–E657.

The Stanford University Experience With Conventional-Dose, Total Skin Electron-Beam Therapy in the Treatment of Generalized Patch or Plaque (T2) and Tumor (T3) Mycosis Fungoides
Navi, D., Riaz, N., Levin, Y. S., Sullivan, N. C., Kim, Y. H., & Hoppe, R. T. (2011). The Stanford University Experience With Conventional-Dose, Total Skin Electron-Beam Therapy in the Treatment of Generalized Patch or Plaque (T2) and Tumor (T3) Mycosis Fungoides. ARCHIVES OF DERMATOLOGY, 147(5), 561–67.

Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
Olsen, E. A., Whittaker, S., Kim, Y. H., Duvic, M., Prince, H. M., Lessin, S. R., … Vonderheid, E. C. (2011). Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. JOURNAL OF CLINICAL ONCOLOGY, 29(18), 2598–2607.

Radiotherapy Planning for the Lymphomas: Expanding Roles for Biologic Imaging
Hoppe, R. (2011). Radiotherapy Planning for the Lymphomas: Expanding Roles for Biologic Imaging. IMRT IGRT SBRT- ADVANCES IN THE TREATMENT PLANNING AND DELIVERY OF RADIOTHERAPY, 43, 331–43.

Treatment strategies in limited stage follicular NHL
Hoppe, R. T. (2011). Treatment strategies in limited stage follicular NHL. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 24(2), 179–86.

In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
Kim, Y. H., Gratzinger, D., Harrison, C., Brody, J. D., Czerwinski, D. K., Ai, W. Z., … Levy, R. (2012). In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study. BLOOD, 119(2), 355–63.

Interim-treatment quantitative PET parameters predict progression and death among patients with hodgkin's disease
Tseng, D., Rachakonda, L. P., Su, Z., Advani, R., Horning, S., Hoppe, R. T., … Tran, P. T. (2012). Interim-treatment quantitative PET parameters predict progression and death among patients with hodgkin's disease. RADIATION ONCOLOGY, 7.

Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment.
Hoppe, R. T., Wood, G. S., & Abel, E. A. (1990). Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment. Current Problems in Cancer, 14(6), 293–371.

RADIATION-THERAPY IN THE MANAGEMENT OF HODGKINS-DISEASE
Hoppe, R. T. (1990). RADIATION-THERAPY IN THE MANAGEMENT OF HODGKINS-DISEASE. SEMINARS IN ONCOLOGY, 17(6), 704–715.

A Tribute to Malcolm A. Bagshaw-An Innovative Physician Who Soared to Success
Hoppe, R. T., & Donaldson, S. S. (2012). A Tribute to Malcolm A. Bagshaw-An Innovative Physician Who Soared to Success. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 83(1), 6–7.

DISCORDANT EXPRESSION OF ANTIGENS BETWEEN INTRAEPIDERMAL AND INTRADERMAL T-CELLS IN MYCOSIS-FUNGOIDES
Michie, S. A., Abel, E. A., Hoppe, R. T., Warnke, R. A., & Wood, G. S. (1990). DISCORDANT EXPRESSION OF ANTIGENS BETWEEN INTRAEPIDERMAL AND INTRADERMAL T-CELLS IN MYCOSIS-FUNGOIDES. AMERICAN JOURNAL OF PATHOLOGY, 137(6), 1447–51.

Long-term outcomes after high dose therapy and autologous haematopoietic cell rescue for refractory/relapsed Hodgkin lymphoma
Minn, A. Y., Riedel, E., Halpern, J., Johnston, L. J., Horning, S. J., Hoppe, R. T., & Goodman, K. A. (2012). Long-term outcomes after high dose therapy and autologous haematopoietic cell rescue for refractory/relapsed Hodgkin lymphoma. BRITISH JOURNAL OF HAEMATOLOGY, 159(3), 329–39.

PROGNOSTIC FACTORS FOR PATIENTS RELAPSING AFTER RADIOTHERAPY FOR EARLY-STAGE HODGKINS-DISEASE
Roach, M., Brophy, N., Cox, R., Varghese, A., & Hoppe, R. T. (1990). PROGNOSTIC FACTORS FOR PATIENTS RELAPSING AFTER RADIOTHERAPY FOR EARLY-STAGE HODGKINS-DISEASE. JOURNAL OF CLINICAL ONCOLOGY, 8(4), 623–629.

Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial
Advani, R. H., Hoppe, R. T., Baer, D., Mason, J., Warnke, R., Allen, J., … Horning, S. J. (2013). Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial. ANNALS OF ONCOLOGY, 24(4), 1044–48.

Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)
Gordon, L. I., Hong, F., Fisher, R. I., Bartlett, N. L., Connors, J. M., Gascoyne, R. D., … Horning, S. J. (2013). Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496). JOURNAL OF CLINICAL ONCOLOGY, 31(6), 684–91.

Risk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma: The Stanford University Experience Over Three Generations of Clinical Trials
Koontz, M. Z., Horning, S. J., Balise, R., Greenberg, P. L., Rosenberg, S. A., Hoppe, R. T., & Advani, R. H. (2013). Risk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma: The Stanford University Experience Over Three Generations of Clinical Trials. JOURNAL OF CLINICAL ONCOLOGY, 31(5), 592–98.

RADIATION-THERAPY IN THE MANAGEMENT OF BULKY MEDIASTINAL HODGKINS-DISEASE
BEHAR, R. A., & Hoppe, R. T. (1990). RADIATION-THERAPY IN THE MANAGEMENT OF BULKY MEDIASTINAL HODGKINS-DISEASE. CANCER, 66(1), 75–79.

Evolution of the techniques of radiation therapy in the management of lymphoma
Hoppe, R. T. (2013). Evolution of the techniques of radiation therapy in the management of lymphoma. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 18(3), 359–63.

Low-dose radiation therapy (2 Gy × 2) in the treatment of orbital lymphoma.
Fasola, C. E., Jones, J. C., Huang, D. D., Le, Q.-T., Hoppe, R. T., & Donaldson, S. S. (2013). Low-dose radiation therapy (2 Gy × 2) in the treatment of orbital lymphoma. International Journal of Radiation Oncology, Biology, Physics, 86(5), 930–35.

MINIMAL LONG-TERM CARDIOPULMONARY DYSFUNCTION FOLLOWING TREATMENT FOR HODGKINS-DISEASE
WATCHIE, J., Coleman, C. N., Raffin, T. A., Cox, R. S., Raubitschek, A. A., Fahey, T., … VANKESSEL, A. (1987). MINIMAL LONG-TERM CARDIOPULMONARY DYSFUNCTION FOLLOWING TREATMENT FOR HODGKINS-DISEASE. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 13(4), 517–24.

VINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE
Horning, S. J., Hoppe, R. T., Hancock, S. L., & Rosenberg, S. A. (1988). VINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE. JOURNAL OF CLINICAL ONCOLOGY, 6(12), 1822–31.

EXPRESSION OF T-CELL RECEPTOR ANTIGENS IN MYCOSIS-FUNGOIDES AND INFLAMMATORY SKIN-LESIONS
Michie, S. A., Abel, E. A., Hoppe, R. T., Warnke, R. A., & Wood, G. S. (1989). EXPRESSION OF T-CELL RECEPTOR ANTIGENS IN MYCOSIS-FUNGOIDES AND INFLAMMATORY SKIN-LESIONS. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 93(1), 116–20.

Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation.
Strober, S., Dhillon, M., Schubert, M., Holm, B., Engleman, E., Benike, C., … Collins, G. (1989). Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation. New England Journal of Medicine, 321(1), 28–33.

SMALL LYMPHOCYTIC LYMPHOMA
Morrison, W. H., Hoppe, R. T., Weiss, L. M., Picozzi, V. J., & Horning, S. J. (1989). SMALL LYMPHOCYTIC LYMPHOMA. JOURNAL OF CLINICAL ONCOLOGY, 7(5), 598–606.

CHARACTERIZATION OF SPLENIC STRUCTURE IN HODGKIN DISEASE BY USING NARROW-BAND FILTRATION OF BACKSCATTERED ULTRASOUND
Friedman, P. A., Sommer, F. G., Chen, H. S., RACHLIN, D. J., & Hoppe, R. (1989). CHARACTERIZATION OF SPLENIC STRUCTURE IN HODGKIN DISEASE BY USING NARROW-BAND FILTRATION OF BACKSCATTERED ULTRASOUND. AMERICAN JOURNAL OF ROENTGENOLOGY, 152(6), 1197–1203.

THE MANAGEMENT OF BULKY MEDIASTINAL HODGKINS-DISEASE
Hoppe, R. T. (1989). THE MANAGEMENT OF BULKY MEDIASTINAL HODGKINS-DISEASE. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 3(2), 265–276.

Current Stanford clinical trials for Hodgkin's disease.
Hoppe, R. T., Horning, S. J., Hancock, S. L., & Rosenberg, S. A. (1989). Current Stanford clinical trials for Hodgkin's disease. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer, 117, 182–90.

EFFECTS OF IRRADIATION ON THE HUMAN IMMUNE-SYSTEM
Hoppe, R. T. (1989). EFFECTS OF IRRADIATION ON THE HUMAN IMMUNE-SYSTEM. Presented at the 23RD ANNUAL SAN FRANCISCO CANCER SYMP : RADIATION TOLERANCE OF NORMAL TISSUES, SAN FRANCISCO,CA: KARGER.

OUTCOME OF THE ACUTE GLOMERULAR INJURY IN PROLIFERATIVE LUPUS NEPHRITIS
Chagnac, A., Kiberd, B. A., Farinas, M. C., Strober, S., Sibley, R. K., Hoppe, R., & Myers, B. D. (1989). OUTCOME OF THE ACUTE GLOMERULAR INJURY IN PROLIFERATIVE LUPUS NEPHRITIS. JOURNAL OF CLINICAL INVESTIGATION, 84(3), 922–30.

CLONAL REARRANGEMENTS OF IMMUNOGLOBULIN GENES AND PROGRESSION TO B-CELL LYMPHOMA IN CUTANEOUS LYMPHOID HYPERPLASIA
Wood, G. S., Ngan, B. Y., Tung, R., HOFFMAN, T. E., Abel, E. A., Hoppe, R. T., … Sklar, J. (1989). CLONAL REARRANGEMENTS OF IMMUNOGLOBULIN GENES AND PROGRESSION TO B-CELL LYMPHOMA IN CUTANEOUS LYMPHOID HYPERPLASIA. AMERICAN JOURNAL OF PATHOLOGY, 135(1), 13–19.

DETECTION OF CLONAL T-CELL RECEPTOR GENE REARRANGEMENTS IN THE PERIPHERAL-BLOOD OF PATIENTS WITH MYCOSIS-FUNGOIDES SEZARY SYNDROME
Weiss, L. M., Wood, G. S., Hu, E., Abel, E. A., Hoppe, R. T., & Sklar, J. (1989). DETECTION OF CLONAL T-CELL RECEPTOR GENE REARRANGEMENTS IN THE PERIPHERAL-BLOOD OF PATIENTS WITH MYCOSIS-FUNGOIDES SEZARY SYNDROME. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 92(4), 601–604.

CUTANEOUS LYMPHOID HYPERPLASIA - IMMUNOLOGICAL CHARACTERISTICS AND ASSESSMENT OF CRITERIA RECENTLY PROPOSED AS DIAGNOSTIC OF MALIGNANT-LYMPHOMA
Medeiros, L. J., Picker, L. J., Abel, E. A., Hu, C. H., Hoppe, R. T., Warnke, R. A., & Wood, G. S. (1989). CUTANEOUS LYMPHOID HYPERPLASIA - IMMUNOLOGICAL CHARACTERISTICS AND ASSESSMENT OF CRITERIA RECENTLY PROPOSED AS DIAGNOSTIC OF MALIGNANT-LYMPHOMA. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 21(5), 929–942.

NON-HODGKIN LYMPHOMA - INFLUENCE OF LYMPHOGRAPHY, CT, AND BONE-MARROW BIOPSY ON STAGING AND MANAGEMENT
Pond, G. D., Castellino, R. A., Horning, S., & Hoppe, R. T. (1989). NON-HODGKIN LYMPHOMA - INFLUENCE OF LYMPHOGRAPHY, CT, AND BONE-MARROW BIOPSY ON STAGING AND MANAGEMENT. RADIOLOGY, 170(1), 159–164.

PROGNOSTIC INDICATORS OF LAPAROTOMY FINDINGS IN CLINICAL STAGE-I-II SUPRADIAPHRAGMATIC HODGKINS-DISEASE
LEIBENHAUT, M. H., Hoppe, R. T., Efron, B., Halpern, J., Nelsen, T., & Rosenberg, S. A. (1989). PROGNOSTIC INDICATORS OF LAPAROTOMY FINDINGS IN CLINICAL STAGE-I-II SUPRADIAPHRAGMATIC HODGKINS-DISEASE. JOURNAL OF CLINICAL ONCOLOGY, 7(1), 81–91.

BENIGN AND MALIGNANT FORMS OF ERYTHRODERMA - CUTANEOUS IMMUNOPHENOTYPIC CHARACTERISTICS
Abel, E. A., LINDAE, M. L., Hoppe, R. T., & Wood, G. S. (1988). BENIGN AND MALIGNANT FORMS OF ERYTHRODERMA - CUTANEOUS IMMUNOPHENOTYPIC CHARACTERISTICS. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 19(6), 1089–1095.

The non-Hodgkin's lymphomas: pathology, staging, treatment.
Hoppe, R. T. (1987). The non-Hodgkin's lymphomas: pathology, staging, treatment. Current Problems in Cancer, 11(6), 363–447.

COMBINED MODALITY THERAPY FOR STAGE-I-II LARGE CELL LYMPHOMA
Prestidge, B. R., Horning, S. J., & Hoppe, R. T. (1988). COMBINED MODALITY THERAPY FOR STAGE-I-II LARGE CELL LYMPHOMA. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 15(3), 633–639.

THE CONTEMPORARY MANAGEMENT OF HODGKIN DISEASE
Hoppe, R. T. (1988). THE CONTEMPORARY MANAGEMENT OF HODGKIN DISEASE. RADIOLOGY, 169(2), 297–304.

T-CELL ANTIGEN DEFICIENCIES AND CLONAL REARRANGEMENTS OF T-CELL RECEPTOR GENES IN PAGETOID RETICULOSIS (WORINGER-KOLOPP DISEASE)
Wood, G. S., Weiss, L. M., Hu, C. H., Abel, E. A., Hoppe, R. T., Warnke, R. A., & Sklar, J. (1988). T-CELL ANTIGEN DEFICIENCIES AND CLONAL REARRANGEMENTS OF T-CELL RECEPTOR GENES IN PAGETOID RETICULOSIS (WORINGER-KOLOPP DISEASE). NEW ENGLAND JOURNAL OF MEDICINE, 318(3), 164–167.

POIKILODERMATOUS MYCOSIS-FUNGOIDES AND ATROPHIC LARGE-PLAQUE PARA-PSORIASIS EXHIBIT SIMILAR ABNORMALITIES OF T-CELL ANTIGEN EXPRESSION
LINDAE, M. L., Abel, E. A., Hoppe, R. T., & Wood, G. S. (1988). POIKILODERMATOUS MYCOSIS-FUNGOIDES AND ATROPHIC LARGE-PLAQUE PARA-PSORIASIS EXHIBIT SIMILAR ABNORMALITIES OF T-CELL ANTIGEN EXPRESSION. ARCHIVES OF DERMATOLOGY, 124(3), 366–372.

DISSECTION OF THE MECHANISMS OF IMMUNE INJURY IN RHEUMATOID-ARTHRITIS, USING TOTAL LYMPHOID IRRADIATION
Gaston, J. S. H., Strober, S., SOLOVERA, J. J., GANDOUR, D., Lane, N., Schurman, D., … Allison, A. C. (1988). DISSECTION OF THE MECHANISMS OF IMMUNE INJURY IN RHEUMATOID-ARTHRITIS, USING TOTAL LYMPHOID IRRADIATION. ARTHRITIS AND RHEUMATISM, 31(1), 21–30.

TREATMENT OF LUPUS NEPHRITIS WITH TOTAL LYMPHOID IRRADIATION - OBSERVATIONS DURING A 12-79-MONTH FOLLOW-UP
Strober, S., Farinas, M. C., Field, E. H., SOLOVERA, J. J., Kiberd, B. A., Myers, B. D., & Hoppe, R. T. (1988). TREATMENT OF LUPUS NEPHRITIS WITH TOTAL LYMPHOID IRRADIATION - OBSERVATIONS DURING A 12-79-MONTH FOLLOW-UP. ARTHRITIS AND RHEUMATISM, 31(7), 850–58.

CLINICAL AND IMMUNOLOGICAL STUDIES OF CADAVERIC RENAL-TRANSPLANT RECIPIENTS GIVEN TOTAL-LYMPHOID IRRADIATION AND MAINTAINED ON LOW-DOSE PREDNISONE
Saper, V., Chow, D., ENGLEMAN, E. D., Hoppe, R. T., Levin, B., Collins, G., & Strober, S. (1988). CLINICAL AND IMMUNOLOGICAL STUDIES OF CADAVERIC RENAL-TRANSPLANT RECIPIENTS GIVEN TOTAL-LYMPHOID IRRADIATION AND MAINTAINED ON LOW-DOSE PREDNISONE. TRANSPLANTATION, 45(3), 540–46.

INTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS
Hancock, S. L., Hoppe, R. T., Horning, S. J., & Rosenberg, S. A. (1988). INTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS. ANNALS OF INTERNAL MEDICINE, 109(3), 183–89.

NODULAR AND DIFFUSE TYPES OF LYMPHOCYTE PREDOMINANCE HODGKINS-DISEASE
Regula, D. P., Hoppe, R. T., & Weiss, L. M. (1988). NODULAR AND DIFFUSE TYPES OF LYMPHOCYTE PREDOMINANCE HODGKINS-DISEASE. NEW ENGLAND JOURNAL OF MEDICINE, 318(4), 214–219.

LUPUS NEPHRITIS AFTER TOTAL LYMPHOID IRRADIATION - PERSISTENT IMPROVEMENT AND REDUCTION OF STEROID-THERAPY
Strober, S., Farinas, M. C., Field, E. H., SOLOVERA, J. J., Kiberd, B. A., Myers, B. D., & Hoppe, R. T. (1987). LUPUS NEPHRITIS AFTER TOTAL LYMPHOID IRRADIATION - PERSISTENT IMPROVEMENT AND REDUCTION OF STEROID-THERAPY. ANNALS OF INTERNAL MEDICINE, 107(5), 689–90.

MYCOSIS-FUNGOIDES - MANAGEMENT WITH TOPICAL NITROGEN-MUSTARD
Hoppe, R. T., Abel, E. A., DENEAU, D. G., & Price, N. M. (1987). MYCOSIS-FUNGOIDES - MANAGEMENT WITH TOPICAL NITROGEN-MUSTARD. JOURNAL OF CLINICAL ONCOLOGY, 5(11), 1796–1803.

SOLITARY PLASMACYTOMA OF BONE - TREATMENT, PROGRESSION, AND SURVIVAL
CHAK, L. Y., Cox, R. S., Bostwick, D. G., & Hoppe, R. T. (1987). SOLITARY PLASMACYTOMA OF BONE - TREATMENT, PROGRESSION, AND SURVIVAL. JOURNAL OF CLINICAL ONCOLOGY, 5(11), 1811–1815.

EFFECT OF FILGRASTIM (G-CSF) IN HODGKINS-DISEASE PATIENTS TREATED WITH RADIATION
Knox, S. J., Fowler, S., Marquez, C., & Hoppe, R. T. (1994). EFFECT OF FILGRASTIM (G-CSF) IN HODGKINS-DISEASE PATIENTS TREATED WITH RADIATION. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 28(2), 445–50.

EFFECT OF TREATMENT FOR HODGKINS-DISEASE ON PULMONARY-FUNCTION - RESULTS OF A PROSPECTIVE-STUDY
Horning, S. J., Adhikari, A., Rizk, N., Hoppe, R. T., & Olshen, R. A. (1994). EFFECT OF TREATMENT FOR HODGKINS-DISEASE ON PULMONARY-FUNCTION - RESULTS OF A PROSPECTIVE-STUDY. JOURNAL OF CLINICAL ONCOLOGY, 12(2), 297–305.

BRIEF CHEMOTHERAPY, STANFORD-V, AND ADJUVANT RADIOTHERAPY FOR BULKY OR ADVANCED-STAGE HODGKINS-DISEASE - A PRELIMINARY-REPORT
Bartlett, N. L., Rosenberg, S. A., Hoppe, R. T., Hancock, S. L., & Horning, S. J. (1995). BRIEF CHEMOTHERAPY, STANFORD-V, AND ADJUVANT RADIOTHERAPY FOR BULKY OR ADVANCED-STAGE HODGKINS-DISEASE - A PRELIMINARY-REPORT. JOURNAL OF CLINICAL ONCOLOGY, 13(5), 1080–88.

PELVIC RELAPSE FOLLOWING SUBTOTAL LYMPHOID IRRADIATION IN EARLY-STAGE HODGKINS-DISEASE - AN ANALYSIS OF RISK, MANAGEMENT, AND OUTCOME
Tate, D. J., & Hoppe, R. T. (1995). PELVIC RELAPSE FOLLOWING SUBTOTAL LYMPHOID IRRADIATION IN EARLY-STAGE HODGKINS-DISEASE - AN ANALYSIS OF RISK, MANAGEMENT, AND OUTCOME. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 32(4), 1239–1244.

MULTIPLE COURSES OF HIGH-DOSE TOTAL SKIN ELECTRON-BEAM THERAPY IN THE MANAGEMENT OF MYCOSIS-FUNGOIDES
Becker, M., Hoppe, R. T., & Knox, S. J. (1995). MULTIPLE COURSES OF HIGH-DOSE TOTAL SKIN ELECTRON-BEAM THERAPY IN THE MANAGEMENT OF MYCOSIS-FUNGOIDES. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 32(5), 1445–1449.

PROGNOSTIC FACTORS IN ERYTHRODERMIC MYCOSIS-FUNGOIDES AND THE SEZARY-SYNDROME
Kim, Y. H., Bishop, K., Varghese, A., & Hoppe, R. T. (1995). PROGNOSTIC FACTORS IN ERYTHRODERMIC MYCOSIS-FUNGOIDES AND THE SEZARY-SYNDROME. ARCHIVES OF DERMATOLOGY, 131(9), 1003–8.

HODGKINS-DISEASE WITH BULKY MEDIASTINAL INVOLVEMENT - EFFECTIVE MANAGEMENT WITH COMBINED MODALITY THERAPY
BEHAR, R. A., Horning, S. J., & Hoppe, R. T. (1993). HODGKINS-DISEASE WITH BULKY MEDIASTINAL INVOLVEMENT - EFFECTIVE MANAGEMENT WITH COMBINED MODALITY THERAPY. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 25(5), 771–776.

CD8-POSITIVE TUMOR-INFILTRATING LYMPHOCYTES INFLUENCE THE LONG-TERM SURVIVAL OF PATIENTS WITH MYCOSIS-FUNGOIDES
Hoppe, R. T., Medeiros, L. J., Warnke, R. A., & Wood, G. S. (1995). CD8-POSITIVE TUMOR-INFILTRATING LYMPHOCYTES INFLUENCE THE LONG-TERM SURVIVAL OF PATIENTS WITH MYCOSIS-FUNGOIDES. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 32(3), 448–453.

TREATMENT OF EARLY-STAGE GASTRIC LYMPHOMA
BenYosef, R., & Hoppe, R. T. (1994). TREATMENT OF EARLY-STAGE GASTRIC LYMPHOMA. JOURNAL OF SURGICAL ONCOLOGY, 57(2), 78–86.

FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE, AND CYCLOPHOSPHAMIDE PLUS AUTOGRAFTING IN HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA
Horning, S. J., Negrin, R. S., Chao, N. J., Long, G. D., Hoppe, R. T., & Blume, K. G. (1994). FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE, AND CYCLOPHOSPHAMIDE PLUS AUTOGRAFTING IN HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA. JOURNAL OF CLINICAL ONCOLOGY, 12(12), 2552–58.

CARDIAC DISEASE FOLLOWING TREATMENT OF HODGKINS-DISEASE IN CHILDREN AND ADOLESCENTS
Hancock, S. L., Donaldson, S. S., & Hoppe, R. T. (1993). CARDIAC DISEASE FOLLOWING TREATMENT OF HODGKINS-DISEASE IN CHILDREN AND ADOLESCENTS. JOURNAL OF CLINICAL ONCOLOGY, 11(7), 1208–15.

FACTORS AFFECTING LATE MORTALITY FROM HEART-DISEASE AFTER TREATMENT OF HODGKINS-DISEASE
Hancock, S. L., TUCKER, M. A., & Hoppe, R. T. (1993). FACTORS AFFECTING LATE MORTALITY FROM HEART-DISEASE AFTER TREATMENT OF HODGKINS-DISEASE. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 270(16), 1949–55.

BREAST-CANCER AFTER TREATMENT OF HODGKINS-DISEASE
Hancock, S. L., TUCKER, M. A., & Hoppe, R. T. (1993). BREAST-CANCER AFTER TREATMENT OF HODGKINS-DISEASE. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 85(1), 25–31.

MYCOSIS-FUNGOIDES - CLINICAL AND HISTOLOGIC FEATURES, STAGING, EVALUATION, AND APPROACH TO TREATMENT
Abel, E. A., Wood, G. S., & Hoppe, R. T. (1993). MYCOSIS-FUNGOIDES - CLINICAL AND HISTOLOGIC FEATURES, STAGING, EVALUATION, AND APPROACH TO TREATMENT. CA-A CANCER JOURNAL FOR CLINICIANS, 43(2), 93–115.

MR-IMAGING TO DETECT CHEST-WALL AND PLEURAL INVOLVEMENT IN PATIENTS WITH LYMPHOMA - EFFECT ON RADIATION-THERAPY PLANNING
CARLSEN, S. E., Bergin, C. J., & Hoppe, R. T. (1993). MR-IMAGING TO DETECT CHEST-WALL AND PLEURAL INVOLVEMENT IN PATIENTS WITH LYMPHOMA - EFFECT ON RADIATION-THERAPY PLANNING. AMERICAN JOURNAL OF ROENTGENOLOGY, 160(6), 1191–1195.

Treatment of cutaneous T-Cell lymphoma with chimeric anti-CD4 monoclonal antibody
Knox, S., Hoppe, R. T., Maloney, D., Gibbs, I., Fowler, S., Marquez, C., … Levy, R. (1996). Treatment of cutaneous T-Cell lymphoma with chimeric anti-CD4 monoclonal antibody. BLOOD, 87(3), 893–99.

Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University
MacManus, M. P., & Hoppe, R. T. (1996). Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. JOURNAL OF CLINICAL ONCOLOGY, 14(4), 1282–1290.

High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: The impact of involved field radiotherapy on patterns of failure and survival
Poen, J. C., Hoppe, R. T., & Horning, S. J. (1996). High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: The impact of involved field radiotherapy on patterns of failure and survival. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 36(1), 3–12.

Hodgkin's disease - The role of radiation therapy in advanced disease
Hoppe, R. T. (1996). Hodgkin's disease - The role of radiation therapy in advanced disease. Presented at the 3rd International Symposium on Hodgkins Lymphoma, COLOGNE,GERMANY: KLUWER ACADEMIC PUBL.

Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: An update
Horning, S. J., Rosenberg, S. A., & Hoppe, R. T. (1996). Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: An update. Presented at the 3rd International Symposium on Hodgkins Lymphoma, COLOGNE,GERMANY: KLUWER ACADEMIC PUBL.

Clinical stage IA (limited patch and plaque) mycosis fungoides - A long-term outcome analysis
Kim, Y. H., Jensen, R. A., WATANABE, G. L., Varghese, A., & Hoppe, R. T. (1996). Clinical stage IA (limited patch and plaque) mycosis fungoides - A long-term outcome analysis. ARCHIVES OF DERMATOLOGY, 132(11), 1309–13.

High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices
Horning, S. J., Chao, N. J., Negrin, R. S., Hoppe, R. T., Long, G. D., Hu, W. W., … Blume, K. G. (1997). High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices. BLOOD, 89(3), 801–13.

Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease
Yuen, A. R., Rosenberg, S. A., Hoppe, R. T., HALPERN, J. D., & Horning, S. J. (1997). Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. BLOOD, 89(3), 814–822.

Gastrointestinal cancer after treatment of Hodgkin's disease
Birdwell, S. H., Hancock, S. L., Varghese, A., Cox, R. S., & Hoppe, R. T. (1997). Gastrointestinal cancer after treatment of Hodgkin's disease. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 37(1), 67–73.

Detection of relapse in early-stage Hodgkin's disease: Role of routine follow-up studies
TORREY, M. J., Poen, J. C., & Hoppe, R. T. (1997). Detection of relapse in early-stage Hodgkin's disease: Role of routine follow-up studies. JOURNAL OF CLINICAL ONCOLOGY, 15(3), 1123–1130.

Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma.
Stockerl-Goldstein, K. E., Horning, S. J., Negrin, R. S., Chao, N. J., Hu, W. W., Long, G. D., … Blume, K. G. (1996). Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma. Biology of Blood and Marrow Transplantation , 2(2), 76–85.

Stanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease: Subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation
Horning, S. J., Hoppe, R. T., Mason, J., Brown, B. W., Hancock, S. L., Baer, D., & Rosenberg, S. A. (1997). Stanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease: Subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation. JOURNAL OF CLINICAL ONCOLOGY, 15(5), 1736–44.

Hodgkin's disease: Complications of therapy and excess mortality
Hoppe, R. T. (1997). Hodgkin's disease: Complications of therapy and excess mortality. Presented at the 6th International Conference on Malignant Lymphoma, LUGANO,SWITZERLAND: OXFORD UNIV PRESS.

Non-Hodgkin's lymphoma of the paranasal sinuses: Clinical and pathological features, and response to combined-modality therapy
Hausdorff, J., Davis, E., Long, G., Hoppe, R., VANDERPAS, M., Lassman, C., … Jacobs, C. (1997). Non-Hodgkin's lymphoma of the paranasal sinuses: Clinical and pathological features, and response to combined-modality therapy. CANCER JOURNAL, 3(5), 303–11.

Long-term depletion of naive T cells in patients treated for Hodgkin's disease
Watanabe, N., DeRosa, S. C., Cmelak, A., Hoppe, R., Herzenberg, L. A., Herzenberg, L. A., & Roederer, M. (1997). Long-term depletion of naive T cells in patients treated for Hodgkin's disease. BLOOD, 90(9), 3662–72.

Long-term results of total lymphoid irradiation in the treatment of cardiac allograft rejection
Wolden, S. L., Tate, D. J., Hunt, S. A., Strober, S., & Hoppe, R. T. (1997). Long-term results of total lymphoid irradiation in the treatment of cardiac allograft rejection. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 39(5), 953–60.

Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
Long, G. D., Amylon, M. D., Stockerl-Goldstein, K. E., Negrin, R. S., Chao, N. J., Hu, W. W., … Blume, K. G. (1997). Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies. Biology of Blood and Marrow Transplantation , 3(6), 324–30.

Mycosis fungoides in young patients: Clinical characteristics and outcome
Crowley, J. J., Nikko, A., Varghese, A., Hoppe, R. T., & Kim, Y. H. (1998). Mycosis fungoides in young patients: Clinical characteristics and outcome. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 38(5), 696–701.

Role of histology in providing prognostic information in mycosis fungoides
SMOLLER, B. R., Detwiler, S. P., Kohler, S., Hoppe, R. T., & Kim, Y. H. (1998). Role of histology in providing prognostic information in mycosis fungoides. JOURNAL OF CUTANEOUS PATHOLOGY, 25(6), 311–15.

Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides
Kim, Y. H., Chow, S., Varghese, A., & Hoppe, R. T. (1999). Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. ARCHIVES OF DERMATOLOGY, 135(1), 26–32.

Radiation therapy as a component of high-dose salvage strategies in Hodgkin's disease.
Hoppe, R. T. (1998). Radiation therapy as a component of high-dose salvage strategies in Hodgkin's disease. Annals of Oncology , 9, S87–90.

Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials
Franklin, J., Pluetschow, A., Paus, M., Specht, L., Anselmo, A.-P., Aviles, A., … Yahalom, J. (2006). Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. ANNALS OF ONCOLOGY, 17(12), 1749–60.

Closing the gap: A comparison of observed versus expected survival in follicular lymphoma (FL) at Stanford University from 1960-2003
Tan, D., Rosenberg, S. A., Lavori, P., Sigal, B. M., Levy, R., Hoppe, R. T., … Horning, S. J. (2008). Closing the gap: A comparison of observed versus expected survival in follicular lymphoma (FL) at Stanford University from 1960-2003. JOURNAL OF CLINICAL ONCOLOGY, 26(15).

Classical Hodgkin Lymphoma in First Complete Remission: Is There a Role for F-18 FDG PET/CT Surveillance?
Lagaru, A., Maeda, L. S., Lin, F. I., Hoppe, R. T., Rosenberg, S. A., Gambhir, S. S., & Advani, R. H. (2010). Classical Hodgkin Lymphoma in First Complete Remission: Is There a Role for F-18 FDG PET/CT Surveillance? Presented at the 23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), VIENNA,AUSTRIA,AUSTRIA,AUSTRIA,AUSTRIA,AUSTRIA,AUSTRIA,AUSTRIA,AUSTRIA,AUSTRIA: SPRINGER.

Survival in follicular lymphoma: The Stanford experience, 1960-2003.
Tan, D., Rosenberg, S. A., Levy, R., Lavori, P., Tibshirani, R., Hoppe, R. T., … Horning, S. J. (2007). Survival in follicular lymphoma: The Stanford experience, 1960-2003. BLOOD, 110(11), 1005A–1005A.

Improved prognosis after histologic transformation (HT) of follicular lymphoma (FL): The Stanford experience 1960-2003
Tan, D., Rosenberg, S. A., Lavori, P., Levy, R., Hoppe, R., Warnke, R., … Horning, S. J. (2008). Improved prognosis after histologic transformation (HT) of follicular lymphoma (FL): The Stanford experience 1960-2003. Presented at the 10th International Conference on Malignant Lymphoma, LUGANO,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND: OXFORD UNIV PRESS.

Clinical and immunologic responses to a novel in situ lymphoma vaccine maneuver: Results of a phase II trial of intra-tumoral CPG-[PF-3512676]
Brody, J. D., Ai, W. Z., Czerwinski, D. K., Advani, R., Horning, S. J., Hoppe, R. T., & Levy, R. (2008). Clinical and immunologic responses to a novel in situ lymphoma vaccine maneuver: Results of a phase II trial of intra-tumoral CPG-[PF-3512676]. Presented at the 10th International Conference on Malignant Lymphoma, LUGANO,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND: OXFORD UNIV PRESS.

In Situ Vaccination with TLR9 Agonist Combined with Local Radiation In Mycosis Fungoides: Analysis of Phase I/II Study
Kim, Y. H., Gratzinger, D., Harrison, C., Brody, J., Czerwinski, D., Xing, L., … Levy, R. (2010). In Situ Vaccination with TLR9 Agonist Combined with Local Radiation In Mycosis Fungoides: Analysis of Phase I/II Study. BLOOD. ORLANDO,FL,FL,FL,FL,FL,FL,FL,FL,FL,FL,FL: AMER SOC HEMATOLOGY.

in Situ Vaccination for Patients with Previously Untreated Follicular Lymphoma: Analysis of Immune Responses
Czerwinski, D. K., Brody, J., Kohrt, H. E., Hoppe, R. T., Advani, R. H., & Levy, R. (2012). in Situ Vaccination for Patients with Previously Untreated Follicular Lymphoma: Analysis of Immune Responses. BLOOD, 120(21).

Second Cancers After Treatment with Stanford V Regimen in Eastern Cooperative Oncology Group (ECOG) Pilot Study E1492 At a Median Follow up of 17 Years
Advani, R. H., Li, H., Hoppe, R. T., Bartlett, N. L., Bennett, J. M., Neuberg, D. S., … Horning, S. J. (2012). Second Cancers After Treatment with Stanford V Regimen in Eastern Cooperative Oncology Group (ECOG) Pilot Study E1492 At a Median Follow up of 17 Years. BLOOD, 120(21).

Non-Hodgkin's Lymphomas
Zelenetz, A. D., Abramson, J. S., Advani, R. H., Andreadis, C. B., Byrd, J. C., Czuczman, M. S., … Yunus, F. (2010). Non-Hodgkin's Lymphomas. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 8(3), 288–334.

NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma
Hoppe, R. T., Advani, R. H., Ai, W. Z., Ambinder, R. F., Bello, C. M., Bierman, P. J., … Yahalom, J. (2011). NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 9(9), 1020–58.

The Stanford experience with utilizing the new WHO classification of cutaneous lymphomas for cutaneous B cell lymphoma
Reddy, S., Kohler, S., Horwitz, S., Sutherland, K., Hoppe, R. T., & Kim, Y. H. (2006). The Stanford experience with utilizing the new WHO classification of cutaneous lymphomas for cutaneous B cell lymphoma. Presented at the 67th Annual Meeting of the Society-for-Investigative-Dermatology, PHILADELPHIA,PA,PA: NATURE PUBLISHING GROUP.

Brentuximab Vedotin Demonstrates Significant Clinical Activity in Relapsed or Refractory Mycosis Fungoides with Variable CD30 Expression
Krathen, M., Sundram, U., Bashey, S., Sutherland, K., Salva, K., Wood, G. S., … Kim, Y. H. (2012). Brentuximab Vedotin Demonstrates Significant Clinical Activity in Relapsed or Refractory Mycosis Fungoides with Variable CD30 Expression. BLOOD, 120(21).

Bexarotene is highly active in the treatment of subcutaneous Panniculitis-like T-cell lymphoma.
Molina, A. M., Advani, R., Reddy, S., Hoppe, R., Friedberg, J. W., Sadan, S., … Horwitz, S. M. (2005). Bexarotene is highly active in the treatment of subcutaneous Panniculitis-like T-cell lymphoma. BLOOD, 106(11), 934A–934A.

Primary cutaneous CD30+ anaplastic large cell lymphoma: Analysis of the Stanford series reveals two clinical subsets of patients.
Reddy, S. A., Liu, H., Kohler, S., Hoppe, R. T., & Kim, Y. H. (2004). Primary cutaneous CD30+ anaplastic large cell lymphoma: Analysis of the Stanford series reveals two clinical subsets of patients. BLOOD, 104(11), 226B–226B.

Prognostic factors in primary cutaneous anaplastic large cell lymphoma: Clinical and molecular characterization of a subset with worse outcome
Woo, D., Jones, C., Vanoli-Storz, M., Kohler, S., Reddy, S., Advani, R., … Kim, Y. (2007). Prognostic factors in primary cutaneous anaplastic large cell lymphoma: Clinical and molecular characterization of a subset with worse outcome. BLOOD, 110(11), 1045A–1045A.

Assessment of favorable (F) versus unfavorable (U) early stage Hodgkin's disease (HD); the Stanford V plus radiotherapy (RT) experience.
Advani, R., Maeda, L., Hoppe, R. T., Breslin, S., Rosenberg, S. A., Baer, D., … Horning, S. J. (2005). Assessment of favorable (F) versus unfavorable (U) early stage Hodgkin's disease (HD); the Stanford V plus radiotherapy (RT) experience. BLOOD, 106(11), 548A–548A.

PET status after Stanford V chemotherapy predicts outcome in Hodgkins disease
Advani, R., Maeda, L., Lavori, P., Hoppe, R., Breslin, S., Rosenberg, S., & Horning, S. (2005). PET status after Stanford V chemotherapy predicts outcome in Hodgkins disease. Presented at the 9th International Conference on Malignant Lymphoma, LUGANO,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND: OXFORD UNIV PRESS.

Role or FDG-PET/CT Surveillance for Patients with Classical Hodgkin's Disease in First Complete Response: The Stanford University Experience.
Maeda, L. S., Horning, S. J., Iagaru, A. H., Lin, F. I., Hoppe, R. T., Rosenberg, S. A., & Advani, R. H. (2009). Role or FDG-PET/CT Surveillance for Patients with Classical Hodgkin's Disease in First Complete Response: The Stanford University Experience. BLOOD, 114(22), 626–26.

Mid-treatment Metabolic Tumor Volume Predicts Progression and Death among Patients with Hodgkin's Disease
Tseng, D., Rachakonda, L. P., Su, Z., Advani, R., Horning, S., Rosenberg, S. A., … Tran, P. T. (2010). Mid-treatment Metabolic Tumor Volume Predicts Progression and Death among Patients with Hodgkin's Disease. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(3), S546–S547.

Exploratory study of brentuximab vedotin (SGN-35), a novel monoclonal antibody-drug-conjugate against CD30, in mycosis fungoides (MF) and Sezary syndrome (SS) demonstrates clinical responses regardless of CD30 expression levels
Bashey, S., Krathen, M., Sutherland, K., Sundram, U., Lingala, B., Horwitz, S., … Kim, Y. (2012). Exploratory study of brentuximab vedotin (SGN-35), a novel monoclonal antibody-drug-conjugate against CD30, in mycosis fungoides (MF) and Sezary syndrome (SS) demonstrates clinical responses regardless of CD30 expression levels. Presented at the 75th Annual Meeting of the Society-for-Investigative-Dermatology, RALEIGH,NC,NC,NC,NC,NC,NC,NC,NC: NATURE PUBLISHING GROUP.

Patterns of Failure in Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma (HL) Treated with ABVD plus Radiotherapy or the Stanford V Regimen in the Randomized Phase III North American Intergroup Trial: E2496
Advani, R., Hong, F., Gordon, L. I., Gascoyne, R. D., Wagner, H., Hoppe, R. T., … Horning, S. J. (2011). Patterns of Failure in Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma (HL) Treated with ABVD plus Radiotherapy or the Stanford V Regimen in the Randomized Phase III North American Intergroup Trial: E2496. BLOOD, 118(21), 696–97.

Hodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelines
Hoppe, R. T., Advani, R. H., Ai, W. Z., Ambinder, R. F., Aoun, P., Bello, C. M., … Sundar, H. (2012). Hodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(5), 589–97.

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496
Evens, A. M., Hong, F., Gordon, L. I., Fisher, R. I., Bartlett, N. L., Connors, J. M., … Horning, S. J. (2013). The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496. BRITISH JOURNAL OF HAEMATOLOGY, 161(1), 76–86.

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas
Senff, N. J., Noordijk, E. M., Kim, Y. H., Bagot, M., Berti, E., Cerroni, L., … Willemze, R. (2008). European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. BLOOD, 112(5), 1600–1609.

Salvage Allogeneic Hematopoietic Cell Transplantation with Fludarabine and Low-Dose Total Body Irradiation after Rejection of First Allografts
Gyurkocza, B., Cao, T. M., Storb, R. F., Lange, T., Leisenring, W., Franke, G. N., … Sandmaier, B. M. (2009). Salvage Allogeneic Hematopoietic Cell Transplantation with Fludarabine and Low-Dose Total Body Irradiation after Rejection of First Allografts. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 15(10), 1314–22.

Efficacy and late effects of Stanford V chemotherapy and radiotherapy in untreated Hodgkin's disease: Mature data in early and advanced stage patients.
Horning, S. J., Hoppe, R. T., Advani, R., Warnke, R., Baer, D., Mason, J., & Rosenberg, S. A. (2004). Efficacy and late effects of Stanford V chemotherapy and radiotherapy in untreated Hodgkin's disease: Mature data in early and advanced stage patients. BLOOD, 104(11), 92A–92A.

Management with topical nitrogen mustard in mycosis fungoides: Update of the Stanford experience
Kim, Y. H., & Hoppe, R. T. (2002). Management with topical nitrogen mustard in mycosis fungoides: Update of the Stanford experience. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 119(1), 234–34.

Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience.
Tan, D., Horning, S. J., Hoppe, R. T., Levy, R., Rosenberg, S. A., Sigal, B. M., … Advani, R. H. (2013). Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. Blood, 122(6), 981–87.

Stage I/II Hodgkin's disease (HD) with bulky mediastinal disease or other risk factors (RF) the Stanford V experience
Advani, R. H., Hoppe, R. T., Rosenberg, S. A., & Horning, S. J. (2007). Stage I/II Hodgkin's disease (HD) with bulky mediastinal disease or other risk factors (RF) the Stanford V experience. Presented at the 7th International Symposium on Hodgkins Lymphoma, COLOGNE,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY: FERRATA STORTI FOUNDATION.

Attitudes and beliefs towards surviorship issues in Hodgkin's disease (HD). Results of focus group discussions with patients treated at stanford university
Advani, R., Rosenberg, S., Talreja, N., Hoppe, R., & Horning, S. (2008). Attitudes and beliefs towards surviorship issues in Hodgkin's disease (HD). Results of focus group discussions with patients treated at stanford university. Presented at the 10th International Conference on Malignant Lymphoma, LUGANO,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND: OXFORD UNIV PRESS.

A prospective trial of involved field radiation (IFRT) plus chemotherapy vs extended field (EFRT) radiation for favorable Hodgkin's disease (HD): Long-term follow-up and implications for current combined modality therapy
Horning, S. J., Hoppe, R. T., Advani, R. H., Breslin, S., McCormick, E., Allen, J., … Rosenberg, S. A. (2007). A prospective trial of involved field radiation (IFRT) plus chemotherapy vs extended field (EFRT) radiation for favorable Hodgkin's disease (HD): Long-term follow-up and implications for current combined modality therapy. Presented at the 7th International Symposium on Hodgkins Lymphoma, COLOGNE,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY: FERRATA STORTI FOUNDATION.

Stage I/II Hodgkin's disease: Comparison of outcomes of patients with bulky mediastinal disease versus other risk factors; the Stanford V experience
Advani, R. H., Hoppe, R. T., Rosenberg, S. A., & Horning, S. J. (2007). Stage I/II Hodgkin's disease: Comparison of outcomes of patients with bulky mediastinal disease versus other risk factors; the Stanford V experience. BLOOD, 110(11), 685A–685A.

Efficacy of Abbreviated Stanford V Chemotherapy and Involved Field Radiotherapy in Early Stage Hodgkin's Disease: Mature Results of the G4 Trial.
Advani, R. H., Hoppe, R. T., Baer, D. M., Mason, J., Rosenberg, S. A., & Horning, S. J. (2009). Efficacy of Abbreviated Stanford V Chemotherapy and Involved Field Radiotherapy in Early Stage Hodgkin's Disease: Mature Results of the G4 Trial. BLOOD, 114(22), 666–67.

Dynamic CD8 T-cell responses to tumor-associated Epstein-Barr virus (EBV) antigens in patients with EBV-negative Hodgkin's disease
Kohrt, H. E., Advani, R., Hoppe, R., Rosenberg, S., Horning, S., & Lee, P. P. (2009). Dynamic CD8 T-cell responses to tumor-associated Epstein-Barr virus (EBV) antigens in patients with EBV-negative Hodgkin's disease. JOURNAL OF CLINICAL ONCOLOGY, 27(15).

Incidence of secondary leukemia/myelodysplasia (AML/MDS) in Hodgkin's disease (HD) with three generations of therapy at Stanford University.
Advani, R. H., Hoppe, R. T., Rosenberg, S. A., & Horning, S. J. (2006). Incidence of secondary leukemia/myelodysplasia (AML/MDS) in Hodgkin's disease (HD) with three generations of therapy at Stanford University. JOURNAL OF CLINICAL ONCOLOGY, 24(18), 426S–426S.

Non-Hodgkin's Lymphomas, Version 1.2013 Featured Updates to the NCCN Guidelines
Zelenetz, A. D., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., … Naganuma, M. (2013). Non-Hodgkin's Lymphomas, Version 1.2013 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 11(3), 257–73.

Low-Dose Radiation Therapy (2 Gy x 2) in the Treatment of Orbital Lymphoma
Fasola, C. E., Jones, J. C., Huang, D. D., Quynh-Thu Le, Q. T., Hoppe, R. T., & Donaldson, S. S. (2013). Low-Dose Radiation Therapy (2 Gy x 2) in the Treatment of Orbital Lymphoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 86(5), 930–35.

Non-Hodgkin's Lymphomas
Zelenetz, A. D., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Bellam, N., … Zafar, N. (2011). Non-Hodgkin's Lymphomas. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 9(5), 484–560.

EXPRESSION OF CLASS-II MAJOR HISTOCOMPATIBILITY ANTIGENS BY KERATINOCYTES IN CUTANEOUS T-CELL LYMPHOMA
Wood, G. S., Michie, S. A., Durden, F., Hoppe, R. T., & Warnke, R. A. (1994). EXPRESSION OF CLASS-II MAJOR HISTOCOMPATIBILITY ANTIGENS BY KERATINOCYTES IN CUTANEOUS T-CELL LYMPHOMA. INTERNATIONAL JOURNAL OF DERMATOLOGY, 33(5), 346–50.

Non-Hodgkin's Lymphomas, Version 3.2012 Featured Updates to the NCCN Guidelines
Zelenetz, A. D., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., … Dwyer, M. A. (2012). Non-Hodgkin's Lymphomas, Version 3.2012 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(12), 1487–98.

Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma.
Weng, W.-K., Armstrong, R., Arai, S., Desmarais, C., Hoppe, R., & Kim, Y. H. (2013). Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma. Science Translational Medicine, 5(214), 214ra171-?

Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma.
Advani, R. H., Horning, S. J., Hoppe, R. T., Daadi, S., Allen, J., Natkunam, Y., & Bartlett, N. L. (2014). Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma. Journal of Clinical Oncology , 32(9), 912–18.

Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma.
Horst, K. C., Hancock, S. L., OGNIBENE, G., Chen, C., Advani, R. H., Rosenberg, S. A., … Hoppe, R. T. (2014). Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma. Annals of Oncology , 25(4), 848–51.

Non-Hodgkin's lymphomas, version 2.2014.
Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., … Sundar, H. (2014). Non-Hodgkin's lymphomas, version 2.2014. Journal of the National Comprehensive Cancer Network , 12(6), 916–46.

Minimal Residual Disease Monitoring with High-Throughput Sequencing of T Cell Receptors in Cutaneous T Cell Lymphoma
Weng, W.-K., Armstrong, R., Arai, S., Desmarais, C., Hoppe, R., & Kim, Y. H. (2013). Minimal Residual Disease Monitoring with High-Throughput Sequencing of T Cell Receptors in Cutaneous T Cell Lymphoma. SCIENCE TRANSLATIONAL MEDICINE, 5(214).

Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)
Specht, L., Yahalom, J., Illidge, T., Berthelsen, A. K., Constine, L. S., Eich, H. T., … Ng, A. (2014). Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG). INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 89(4), 854–62.

Non-Hodgkin's Lymphomas, Version 4.2014.
Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., … Sundar, H. (2014). Non-Hodgkin's Lymphomas, Version 4.2014. Journal of the National Comprehensive Cancer Network , 12(9), 1282–1303.

Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials.
Hoppe, R. T., Harrison, C., Tavallaee, M., Bashey, S., Sundram, U., Li, S., … Kim, Y. H. (2015). Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials. Journal of the American Academy of Dermatology, 72(2), 286–92.

Low Dose (12 Gy) Total Skin Electron Beam Therapy (TSEBT) for Mycosis Fungoides (mf): Results of Three Phase 2 Clinical Trials
Hoppe, R. T., Harrison, C., Tavallaee, M., Bashey, S., Li, S., Million, L., … Kim, Y. H. (2014). Low Dose (12 Gy) Total Skin Electron Beam Therapy (TSEBT) for Mycosis Fungoides (mf): Results of Three Phase 2 Clinical Trials. Presented at the 56th Annual Meeting of the American-Society-for-Radiation-Oncology, SAN FRANCISCO,CA,CA,CA,CA: ELSEVIER SCIENCE INC.

Value of Surveillance Studies for Patients With Stage I to II Diffuse Large B-Cell Lymphoma in the Rituximab Era.
Hiniker, S. M., Pollom, E. L., Khodadoust, M. S., Kozak, M. M., Xu, G., Quon, A., … Hoppe, R. T. (2015). Value of Surveillance Studies for Patients With Stage I to II Diffuse Large B-Cell Lymphoma in the Rituximab Era. International Journal of Radiation Oncology, Biology, Physics, 92(1), 99–106.

Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma in the Modern Era
King, M. T., Donaldson, S. S., Link, M. P., Natkunam, Y., Advani, R. H., & Hoppe, R. T. (2015). Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma in the Modern Era. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 92(1), 67–75.

The Paris Conference "La Radiothérapie de la Maladie de Hodgkin": A First Step in the Cure of Hodgkin Disease.
Hoppe, R. T., & Rosenberg, S. A. (2015). The Paris Conference "La Radiothérapie de la Maladie de Hodgkin": A First Step in the Cure of Hodgkin Disease. International Journal of Radiation Oncology, Biology, Physics, 92(1), 3–4.

Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy
Meyer, R. M., & Hoppe, R. T. (2012). Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 313–21.

How I treat nodular lymphocyte predominant Hodgkin lymphoma
Advani, R. H., & Hoppe, R. T. (2013). How I treat nodular lymphocyte predominant Hodgkin lymphoma. BLOOD, 122(26), 4182–88.

CENTRAL NERVOUS-SYSTEM INVOLVEMENT IN NON-HODGKINS LYMPHOMA - AN ANALYSIS OF 105 CASES
MacKintosh, F. R., Colby, T. V., PODOLSKY, W. J., Burke, J. S., Hoppe, R. T., Rosenfelt, F. P., … KAPLAN, H. S. (1982). CENTRAL NERVOUS-SYSTEM INVOLVEMENT IN NON-HODGKINS LYMPHOMA - AN ANALYSIS OF 105 CASES. CANCER, 49(3), 586–95.

How I treat mycosis fungoides and Sezary syndrome
Prince, H. M., Whittaker, S., & Hoppe, R. T. (2009). How I treat mycosis fungoides and Sezary syndrome. BLOOD, 114(20), 4337–53.

Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy
Meyer, R. M., & Hoppe, R. T. (2012). Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy. BLOOD, 120(23), 4488–95.

Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging.
Iberri, D. J., Hoppe, R. T., & Advani, R. H. (2015). Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging. Current Treatment Options in Oncology, 16(9), 45-?

Hodgkin Lymphoma, Version 2.2015
Hoppe, R. T., Advani, R. H., Ai, W. Z., Ambinder, R. F., Aoun, P., Bello, C. M., … Sundar, H. (2015). Hodgkin Lymphoma, Version 2.2015. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 13(5), 554–86.

Management of nodular lymphocyte predominant Hodgkin lymphoma
Advani, R. H., & Hoppe, R. T. (2015). Management of nodular lymphocyte predominant Hodgkin lymphoma. HEMATOLOGICAL ONCOLOGY, 33, 90–95.

Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial.
Advani, R. H., Hong, F., Fisher, R. I., Bartlett, N. L., Robinson, K. S., Gascoyne, R. D., … Horning, S. J. (2015). Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial. Journal of Clinical Oncology , 33(17), 1936–42.

Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group
Specht, L., Dabaja, B., Illidge, T., Wilson, L. D., & Hoppe, R. T. (2015). Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 92(1), 32–39.

Expert Radiation Oncologist Interpretations of Involved-Site Radiation Therapy Guidelines in the Management of Hodgkin Lymphoma
Hoppe, B. S., & Hoppe, R. T. (2015). Expert Radiation Oncologist Interpretations of Involved-Site Radiation Therapy Guidelines in the Management of Hodgkin Lymphoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 92(1), 40–45.

Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Advani, R. H., Horning, S. J., Hoppe, R. T., Daadi, S., Allen, J., Natkunam, Y., & Bartlett, N. L. (2014). Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Journal of Clinical Oncology , 32(9), 912–18.

Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial
Advani, R. H., Hong, F., Fisher, R. I., Bartlett, N. L., Robinson, K. S., Gascoyne, R. D., … Horning, S. J. (2015). Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial. JOURNAL OF CLINICAL ONCOLOGY, 33(17), 1936–U111.

Non-Hodgkin's Lymphomas, Version 2.2014.
Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., … Sundar, H. (2014). Non-Hodgkin's Lymphomas, Version 2.2014. Journal of the National Comprehensive Cancer Network , 12(6), 916–46.

Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease-the Role of Functional Imaging.
Iberri, D. J., Hoppe, R. T., & Advani, R. H. (2015). Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease-the Role of Functional Imaging. Current Treatment Options in Oncology, 16(9), 360-?

Comment on: "clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 Study)".
Hoppe, R., Illidge, T., Specht, L., Vogelius, I., & Yahalom, J. (2014). Comment on: "clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 Study)". Oncologist, 19(12), 1289-?

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.
Kim, Y. H., Tavallaee, M., Sundram, U., Salva, K. A., Wood, G. S., Li, S., … Horwitz, S. M. (2015). Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project. Journal of Clinical Oncology , 33(32), 3750–58.

Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era
Diefenbach, C. S., Li, H., Hong, F., Gordon, L. I., Fisher, R. I., Bartlett, N. L., … Advani, R. H. (2015). Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era. BRITISH JOURNAL OF HAEMATOLOGY, 171(4), 530–38.

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.
Kim, Y. H., Tavallaee, M., Sundram, U., Salva, K. A., Wood, G. S., Li, S., … Horwitz, S. M. (2015). Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project. Journal of Clinical Oncology , 33(32), 3750–58.

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.
Scarisbrick, J. J., Prince, H. M., Vermeer, M. H., Quaglino, P., Horwitz, S., Porcu, P., … Kim, Y. H. (2015). Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model. Journal of Clinical Oncology , 33(32), 3766–73.

Diffuse Large B-Cell Lymphoma Version 1.2016 Clinical Practice Guidelines in Oncology
Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., … Sundar, H. (2016). Diffuse Large B-Cell Lymphoma Version 1.2016 Clinical Practice Guidelines in Oncology. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 14(2), 196–231.

A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy
Binkley, M. S., Hiniker, S. M., Wu, S., Natkunam, Y., Mittra, E. S., Advani, R. H., & Hoppe, R. T. (2016). A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy. LEUKEMIA & LYMPHOMA, 57(3), 604–8.

Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma.
Horst, K. C., Fero, K. E., Hancock, S. L., Advani, R. H., Ikeda, D. M., Daniel, B., … Hoppe, R. T. (2016). Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma. American Journal of Clinical Oncology, 39(2), 114–19.

A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
Binkley, M. S., Hiniker, S. M., Wu, S., Natkunam, Y., Mittra, E. S., Advani, R. H., & Hoppe, R. T. (2016). A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy. Leukemia & Lymphoma, 57(3), 604–8.

Partial orbit irradiation achieves excellent outcomes for primary orbital lymphoma.
Binkley, M. S., Hiniker, S. M., Donaldson, S. S., & Hoppe, R. T. (2016). Partial orbit irradiation achieves excellent outcomes for primary orbital lymphoma. Practical Radiation Oncology, 6(4), 255–61.

Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma: An International Lymphoma Radiation Oncology Group Multi-institutional Experience.
Million, L., Yi, E. J., Wu, F., von Eyben, R., Campbell, B. A., Dabaja, B., … Hoppe, R. T. (2016). Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma: An International Lymphoma Radiation Oncology Group Multi-institutional Experience. International Journal of Radiation Oncology, Biology, Physics, 95(5), 1454–59.

2 Gy?×?2 for palliative treatment of mantle cell lymphoma.
White, E. C., Advani, R., & Hoppe, R. T. (2016). 2 Gy?×?2 for palliative treatment of mantle cell lymphoma. Leukemia & Lymphoma, 57(9), 2219–21.

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome.
Roemer, M. G. M., Advani, R. H., Ligon, A. H., Natkunam, Y., Redd, R. A., Homer, H., … Shipp, M. A. (2016). PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome. Journal of Clinical Oncology , 34(23), 2690–97.

How I treat mycosis fungoides and Sezary syndrome
Whittaker, S., Hoppe, R., & Prince, H. M. (2016). How I treat mycosis fungoides and Sezary syndrome. BLOOD, 127(25), 3142–53.

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.
Horwitz, S. M., Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., … Porcu, P. (2016). NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016. Journal of the National Comprehensive Cancer Network , 14(9), 1067–79.

ACQUIRED IMMUNE TOLERANCE TO CADAVERIC RENAL-ALLOGRAFTS - A STUDY OF 3 PATIENTS TREATED WITH TOTAL LYMPHOID IRRADIATION
Strober, S., Dhillon, M., Schubert, M., Holm, B., Engleman, E., Benike, C., … Levin, B. (1989). ACQUIRED IMMUNE TOLERANCE TO CADAVERIC RENAL-ALLOGRAFTS - A STUDY OF 3 PATIENTS TREATED WITH TOTAL LYMPHOID IRRADIATION. NEW ENGLAND JOURNAL OF MEDICINE, 321(1), 28–33.

Brief report: Tolerance and chimerism after renal and hematopoietic-cell transplantation
Scandling, J. D., Busque, S., Dejbakhsh-Jones, S., Benike, C., Millan, M. T., Shizuru, J. A., … Strober, S. (2008). Brief report: Tolerance and chimerism after renal and hematopoietic-cell transplantation. NEW ENGLAND JOURNAL OF MEDICINE, 358(4), 362–68.

FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 99 PATIENTS WITH ACUTE-LEUKEMIA IN 1ST COMPLETE REMISSION
Snyder, D. S., Chao, N. J., Amylon, M. D., Taguchi, J., Long, G. D., Negrin, R. S., … Blume, K. G. (1993). FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 99 PATIENTS WITH ACUTE-LEUKEMIA IN 1ST COMPLETE REMISSION. BLOOD, 82(9), 2920–28.

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA DURING 1ST COMPLETE REMISSION
Chao, N. J., Forman, S. J., Schmidt, G. M., Snyder, D. S., Amylon, M. D., KONRAD, P. N., … Blume, K. G. (1991). ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA DURING 1ST COMPLETE REMISSION. BLOOD, 78(8), 1923–27.

Classical Hodgkin Lymphoma with Reduced ß2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status.
Roemer, M. G. M., Advani, R. H., Redd, R. A., Pinkus, G. S., Natkunam, Y., Ligon, A. H., … Rodig, S. J. (2016). Classical Hodgkin Lymphoma with Reduced ß2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status. Cancer Immunology Research, 4(11), 910–16.

Non-Hodgkin's Lymphomas, Version 3.2016 Featured Updates to the NCCN Guidelines
Horwitz, S. M., Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., … Porcu, P. (2016). Non-Hodgkin's Lymphomas, Version 3.2016 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 14(9), 1067–79.

NCCN Guidelines (R) Insights Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017 Featured Updates to the NCCN Guidelines
Wierda, W. G., Zelenetz, A. D., Gordon, L. I., Abramson, J. S., Advani, R. H., Andreadis, C. B., … Sundar, H. (2017). NCCN Guidelines (R) Insights Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 15(3), 293–311.

Hodgkin Lymphoma Version 1.2017
Hoppe, R. T., Advani, R. H., Ai, W. Z., Ambinder, R. F., Aoun, P., Bello, C. M., … Sundar, H. (2017). Hodgkin Lymphoma Version 1.2017. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 15(5), 608–38.

Localized skin-limited blastic plasmacytoid dendritic cell neoplasm: A subset with possible durable remission without transplantation.
Amitay-Laish, I., Sundram, U., Hoppe, R. T., Hodak, E., Medeiros, B. C., & Kim, Y. H. (2017). Localized skin-limited blastic plasmacytoid dendritic cell neoplasm: A subset with possible durable remission without transplantation. JAAD Case Reports, 3(4), 310–15.

Phase I/II study of intratumoral injection of SD-101, an immunostimulatory CpG, and intratumoral injection of ipillumumab, an anti-CTLA-4 monoclonal antibody, in combination with local radiation in low-grade B-cell lymphomas.
Khodadoust, M. S., Chu, M. P., Czerwinski, D., McDonald, K., Long, S., Kohrt, H. E., … Levy, R. (2015). Phase I/II study of intratumoral injection of SD-101, an immunostimulatory CpG, and intratumoral injection of ipillumumab, an anti-CTLA-4 monoclonal antibody, in combination with local radiation in low-grade B-cell lymphomas. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
Roemer, M. G. M., Advani, R. H., Ligon, A. H., Natkunam, Y., Redd, R. A., Homer, H., … Shipp, M. A. (2015). PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome. BLOOD, 126(23).

Frontline Therapy of Nodular Lymphocyte Predominant Hodgkin Lymphoma with Rituximab: The Stanford University Experience
Advani, R. H., Horning, S. J., Hoppe, R. T., Daadi, S., Allen, J., Natkunam, Y., … Bartlett, N. L. (2011). Frontline Therapy of Nodular Lymphocyte Predominant Hodgkin Lymphoma with Rituximab: The Stanford University Experience. BLOOD, 118(21), 1154.

Value of surveillance studies for patients (pts) with stage I-II diffuse large B-cell lymphoma (DLBCL) in the rituximab (R) era.
Hiniker, S. M., Pollom, E. L., Khodadoust, M. S., Kozak, M. M., Advani, R. H., & Hoppe, R. T. (2014). Value of surveillance studies for patients (pts) with stage I-II diffuse large B-cell lymphoma (DLBCL) in the rituximab (R) era. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

NCCN Guidelines (R) Insights Hodgkin Lymphoma, Version 1.2018 Featured Updates to the NCCN Guidelines
Hoppe, R. T., Advani, R. H., Ai, W. Z., Ambinder, R. F., Aoun, P., Armand, P., … Ogba, N. (2018). NCCN Guidelines (R) Insights Hodgkin Lymphoma, Version 1.2018 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 16(3), 245–54.

The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group
Constine, L. S., Yahalom, J., Ng, A. K., Hodgson, D. C., Wirth, A., Milgrom, S. A., … Hoppe, R. T. (2018). The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 100(5), 1100–1118.

Post-treatment surveillance imaging in lymphoma
Hiniker, S. M., & Hoppe, R. T. (2017). Post-treatment surveillance imaging in lymphoma. SEMINARS IN ONCOLOGY, 44(5), 310–22.

NCCN Guidelines (R) Insights T-Cell Lymphomas, Version 2.2018 Featured Updates to the NCCN Guidelines
Horwitz, S. M., Ansell, S. M., Ai, W. Z., Barnes, J., Barta, S. K., Choi, M., … Sundar, H. (2018). NCCN Guidelines (R) Insights T-Cell Lymphomas, Version 2.2018 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 16(2), 123–35.

Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations
Diefenbach, C. S., Connors, J. M., Friedberg, J. W., Leonard, J. P., Kahl, B. S., Little, R. F., … Bartlett, N. L. (2017). Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 109(4).

Non-Myeloablative Allogeneic Transplantation Resulting in Clinical and Molecular Remission with Low Non-Relapse Mortality (NRM) in Patients with Advanced Stage Mycosis Fungoides (MF) and Sezary Syndrome (SS)
Weng, W.-K., Armstrong, R., Arai, S., Johnston, L., Laport, G. G., Lowsky, R., … Kim, Y. H. (2014). Non-Myeloablative Allogeneic Transplantation Resulting in Clinical and Molecular Remission with Low Non-Relapse Mortality (NRM) in Patients with Advanced Stage Mycosis Fungoides (MF) and Sezary Syndrome (SS). BLOOD, 124(21).

Outcome of Tandem Autologous/Allogeneic Hematopoietic Cell Transplantation in High-Risk Non Hodgkin's Lymphoma Patients: Stanford University Experience
Wudhikarn, K., Lavori, P., Arai, S., Johnston, L., Laport, G. G., Lowsky, R., … Weng, W.-K. (2014). Outcome of Tandem Autologous/Allogeneic Hematopoietic Cell Transplantation in High-Risk Non Hodgkin's Lymphoma Patients: Stanford University Experience. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC.

Allogeneic transplantation using TLI-ATG conditioning for Hodgkin lymphoma after failure of autologous transplantation.
Spinner, M. A., Advani, R. H., Hoppe, R. T., Lowsky, R., & Muffly, L. S. (2018). Allogeneic transplantation using TLI-ATG conditioning for Hodgkin lymphoma after failure of autologous transplantation. Blood Advances, 2(13), 1547–50.

Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group
Yahalom, J., Illidge, T., Specht, L., Hoppe, R. T., Li, Y.-X., Tsang, R., & Wirth, A. (2015). Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 92(1), 11–31.

Use of High-Throughput Sequencing (HTS) of TCR beta to Determine the Kinetics of Graft-Versus-Lymphoma (GVL) Effect and T-Cell Repertoire Profiles after Allogeneic Transplant
Weng, W.-K., Armstrong, R., Arai, S., Hoppe, R. T., Meyer, E. H., & Kim, Y. H. (2014). Use of High-Throughput Sequencing (HTS) of TCR beta to Determine the Kinetics of Graft-Versus-Lymphoma (GVL) Effect and T-Cell Repertoire Profiles after Allogeneic Transplant. BLOOD. AMER SOC HEMATOLOGY.

A Cutaneous Lymphoma International Consortium 'CLIC' study of Prognostic Parameters in Advanced Stages of Mycosis Fungoides and Sezary Syndrome: Progress Towards Establishing a Prognostic Index to Augment Clinical Staging
Scarisbrick, J. J., Quaglino, P., Vermeer, M., Whittaker, S., Wood, G. S., Duvic, M., … Kim, Y. H. (2014). A Cutaneous Lymphoma International Consortium 'CLIC' study of Prognostic Parameters in Advanced Stages of Mycosis Fungoides and Sezary Syndrome: Progress Towards Establishing a Prognostic Index to Augment Clinical Staging. BLOOD. AMER SOC HEMATOLOGY.

Are Advanced Radiation Therapy Technologies Required for Treating Patients With Hodgkin Lymphoma?
Hoppe, R. T. (2016). Are Advanced Radiation Therapy Technologies Required for Treating Patients With Hodgkin Lymphoma? JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 14(1), 2–3.

Graft-Versus-Lymphoma Effect After Non-Myeloablative Allogeneic Transplant Induces Molecular Remission Assessed by High-Throughput Sequencing of T Cell Receptor in Patients with Advanced Stage Mycosis Fungoides and Sezary Syndrome
Weng, W.-K., Armstrong, R., Arai, S., Sutherland, K., Hoppe, R. T., & Kim, Y. H. (2011). Graft-Versus-Lymphoma Effect After Non-Myeloablative Allogeneic Transplant Induces Molecular Remission Assessed by High-Throughput Sequencing of T Cell Receptor in Patients with Advanced Stage Mycosis Fungoides and Sezary Syndrome. BLOOD. AMER SOC HEMATOLOGY.

Principles of Radiation Techniques in Hodgkin Lymphoma
Yahalom, J., & Hoppe, R. T. (2011). Principles of Radiation Techniques in Hodgkin Lymphoma. HODGKIN LYMPHOMA: A COMPREHENSIVE UPDATE ON DIAGNOSTICS AND CLINICS, 117–39.

Bulky Mediastinal Classical Hodgkin Lymphoma in Young Women
Percival, M.-E. M., Hoppe, R. T., & Advani, R. H. (2014). Bulky Mediastinal Classical Hodgkin Lymphoma in Young Women. ONCOLOGY-NEW YORK, 28(3), 253-+.

Remarkable Advances in the Management of Mycosis Fungoides and the Sezary Syndrome
Hoppe, R. T. (2017). Remarkable Advances in the Management of Mycosis Fungoides and the Sezary Syndrome. ONCOLOGY RESEARCH AND TREATMENT, 40(5), 242–43.

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides or Sezary Syndrome: Final Results Show Significant Clinical Activity and Suggest Correlation with CD30 Expression
Kim, Y. H., Tavallaee, M., Rozati, S., Sundram, U., Salva, K., Wood, G. S., … Horwitz, S. M. (2014). Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides or Sezary Syndrome: Final Results Show Significant Clinical Activity and Suggest Correlation with CD30 Expression. BLOOD, 124(21).

Randomized Phase III Trial Comparing ABVD plus Radiotherapy and the Stanford V.Regimen In Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma: A-Subset Analysis of the US Intergroup Trial E2496
Advani, R., Hong, F., Fisher, R. I., Bartlett, N. L., Robinson, S., Gascoyne, R. D., … Horning, S. J. (2010). Randomized Phase III Trial Comparing ABVD plus Radiotherapy and the Stanford V.Regimen In Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma: A-Subset Analysis of the US Intergroup Trial E2496. BLOOD, 116(21), 185–86.

Re-Examining the Role of Radiation Therapy for Diffuse Large B-Cell Lymphoma in the Modern Era
Ng, A. K., Dabaja, B. S., Hoppe, R. T., Illidge, T., & Yahalom, J. (2016). Re-Examining the Role of Radiation Therapy for Diffuse Large B-Cell Lymphoma in the Modern Era. JOURNAL OF CLINICAL ONCOLOGY, 34(13), 1443-+.

Feasibility of a Table-Top Total Body Irradiation Technique using Robotic Couch Motion
Chin, E., Otto, K., Hoppe, R., Hsu, A., Loo, B., Million, L., … Fahimian, B. (2014). Feasibility of a Table-Top Total Body Irradiation Technique using Robotic Couch Motion. MEDICAL PHYSICS, 41(8), 15.

Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee
Tseng, Y. D., Cutter, D. J., Plastaras, J. P., Parikh, R. R., Cahlon, O., Chuong, M. D., … Hoppe, B. S. (2017). Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 99(4), 825–42.

Biological characterization of stage I follicular lymphoma according to extranodal or nodal primary origin and t(14;18) status using high-resolution array-based comparative genomic hybridization
Weinberg, O. K., Ma, L., Hoppe, R. T., & Arber, D. A. (2015). Biological characterization of stage I follicular lymphoma according to extranodal or nodal primary origin and t(14;18) status using high-resolution array-based comparative genomic hybridization. AMERICAN JOURNAL OF HEMATOLOGY, 90(8), E151.

Dose-Escalated, Intratumoral TLR9 Agonist and Low-Dose Radiation Induce Abscopal Effects in Follicular Lymphoma
Kohrt, H. E., Chu, J., Brody, J., Czerwinski, D. K., Chester, C., Sadaram, M., … Levy, R. (2014). Dose-Escalated, Intratumoral TLR9 Agonist and Low-Dose Radiation Induce Abscopal Effects in Follicular Lymphoma. BLOOD, 124(21).

A Randomized Phase III Trial of ABVD Vs. Stanford V +/- Radiation Therapy In Locally Extensive and Advanced Stage Hodgkin's Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperatve Oncology Group (E2496)
Gordon, L. I., Hong, F., Fisher, R. I., Bartlett, N. L., Connors, J. M., Gascoyne, R. D., … Horning, S. J. (2010). A Randomized Phase III Trial of ABVD Vs. Stanford V +/- Radiation Therapy In Locally Extensive and Advanced Stage Hodgkin's Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperatve Oncology Group (E2496). BLOOD, 116(21), 185.

In Situ Vaccination with a TLR 9 Agonist and Local Low Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma.
Frank, M. J., Reagan, P. M., Bartlett, N. L., Gordon, L. I., Friedberg, J. W., Czerwinski, D. K., … Levy, R. (2018). In Situ Vaccination with a TLR 9 Agonist and Local Low Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma. Cancer Discovery.

Relationship Between Mixed Chimerism and Acceptance of HLA-matched and -Mismatched Kidney Transplants after Withdrawal of Immunosuppressive Drugs
Busque, S., Scandling, J., Lowsky, R., Shizuru, J., Jensen, K., Shori, A., … Strober, S. (2018). Relationship Between Mixed Chimerism and Acceptance of HLA-matched and -Mismatched Kidney Transplants after Withdrawal of Immunosuppressive Drugs. TRANSPLANTATION. LIPPINCOTT WILLIAMS & WILKINS.

Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG.
Brady, J. L., Binkley, M. S., Hajj, C., Chelius, M., Chau, K., Balogh, A., … Mikhaeel, N. G. (2018). Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG. Blood.

Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy.
Moding, E. J., Advani, R., Rosenberg, S. A., & Hoppe, R. T. (2018). Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 129(3), 507–12.

Larry Emanuel Kun, March 10, 1946-May 27, 2018.
FitzGerald, T. J., Donaldson, S. S., Wharam, M., Laurie, F., Bishop-Jodoin, M., Moni, J., … Roberts, K. B. (2019). Larry Emanuel Kun, March 10, 1946-May 27, 2018. International Journal of Radiation Oncology, Biology, Physics, 103(1), 8–14.

Nonmyeloablative Allogeneic Transplantation Using TLI-ATG Conditioning for Lymphoid and Myeloid Malignancies: Mature Follow-up from a Large, Single Institution Cohort
Spinner, M. A., Kennedy, V. E., Tamaresis, J. S., Lavori, P. W., Elder, L. V., Arai, S., … Lowsky, R. (2018). Nonmyeloablative Allogeneic Transplantation Using TLI-ATG Conditioning for Lymphoid and Myeloid Malignancies: Mature Follow-up from a Large, Single Institution Cohort. BLOOD. AMER SOC HEMATOLOGY.

No Utility of Routine Laboratory Testing during Surveillance in Detecting Relapse in Patients with Classic Hodgkin Lymphoma in First Remission
Lynch, R. C., Sundaram, V., Desai, M., Henry, S., Wood, D., Daadi, S., … Advani, R. (2018). No Utility of Routine Laboratory Testing during Surveillance in Detecting Relapse in Patients with Classic Hodgkin Lymphoma in First Remission. BLOOD, 132.

Volumetric modulated arc therapy and 3-dimensional printed bolus in the treatment of refractory primary cutaneous gamma delta lymphoma of the bilateral legs.
Obeid, J.-P., Gutkin, P. M., Lewis, J., Skinner, L., Wang, E. B., Khodadoust, M. S., … Hiniker, S. M. (2019). Volumetric modulated arc therapy and 3-dimensional printed bolus in the treatment of refractory primary cutaneous gamma delta lymphoma of the bilateral legs. Practical Radiation Oncology.

Salvage treatment and survival for relapsed follicular lymphoma following primary radiotherapy: A collaborative study on behalf of ILROG.
Binkley, M. S., Brady, J. L., Hajj, C., Chelius, M., Chau, K., Balogh, A., … Hoppe, R. T. (2019). Salvage treatment and survival for relapsed follicular lymphoma following primary radiotherapy: A collaborative study on behalf of ILROG. International Journal of Radiation Oncology, Biology, Physics.

Results of a prospective phase II trial of limited and extended rituximab treatment in nodular lymphocyte predominant Hodgkin's disease (NLPHD)
Horning, S. J., Bartlett, N. L., Breslin, S., Advani, R. H., Hoppe, R. T., Ekstrand, B. C., & Lucas, J. B. (2007). Results of a prospective phase II trial of limited and extended rituximab treatment in nodular lymphocyte predominant Hodgkin's disease (NLPHD). BLOOD, 110(11), 198A.

Marked improvement in staging accuracy in mycosis fungoides/Sezary syndrome using integrated positron emission tomography and computed tomography (PET/CT)
Tsai, E. Y., Taur, A., Espinosa, L., Quon, A., Dick, S. E., Chow, S., … Kim, Y. H. (2004). Marked improvement in staging accuracy in mycosis fungoides/Sezary syndrome using integrated positron emission tomography and computed tomography (PET/CT). BLOOD, 104(11), 854A–855A.

Primary radiotherapy is curative for CS I-E orbital malt lymphoma
Eulau, S. M., Hildebrand, R., Warnke, R., Donaldson, S. S., & Hoppe, R. T. (1997). Primary radiotherapy is curative for CS I-E orbital malt lymphoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 39(2), 176.

The John Ultmann lecture - the role of radiation therapy in the treatment of Hodgkin's disease: past, present, and future
Hoppe, R. T. (2005). The John Ultmann lecture - the role of radiation therapy in the treatment of Hodgkin's disease: past, present, and future. EUROPEAN JOURNAL OF HAEMATOLOGY, 75, 14–20.

A Single-Arm PHASE 2A Study of NM-IL-12 (rHu-IL12) in Patients with Mycosis Fungoides-Type CTCL (MF) Undergoing Low-Dose TOTAL Skin Electron BEAM Therapy (LD-TSEBT)
Kim, Y. H., Hoppe, R. T., Rook, A. H., Maity, A., Geskin, L. J., Horowitz, D. P., … Basile, L. A. (2016). A Single-Arm PHASE 2A Study of NM-IL-12 (rHu-IL12) in Patients with Mycosis Fungoides-Type CTCL (MF) Undergoing Low-Dose TOTAL Skin Electron BEAM Therapy (LD-TSEBT). BLOOD. AMER SOC HEMATOLOGY.

PROGRESS IN THE TREATMENT OF HODGKINS-DISEASE IN THE UNITED-STATES, 1973 VERSUS 1983 - THE PATTERNS OF CARE STUDY
HOPPE, R. T., HANLON, A. L., HANKS, G. E., & OWEN, J. B. (1994). PROGRESS IN THE TREATMENT OF HODGKINS-DISEASE IN THE UNITED-STATES, 1973 VERSUS 1983 - THE PATTERNS OF CARE STUDY. CANCER, 74(12), 3198–3203.

The clinical spectrum of cutaneous B-cell lymphomas (CBCL): Excellent prognosis for patients with disease limited to the skin.
Mraz-Gernhard, S. M., Horwitz, S., Kim, Y. H., Kohler, S., & Hoppe, R. (2000). The clinical spectrum of cutaneous B-cell lymphomas (CBCL): Excellent prognosis for patients with disease limited to the skin. BLOOD, 96(11), 329A.

Natural killer/natural killer-like T-cell lymphoma (CD56+) presenting in the skin: A study of clinical and pathologic characteristics affecting survival.
Mraz-Gernhard, S. M., Hoppe, R. T., Natkunam, Y., Leboit, P., Kohler, S., & Kim, Y. H. (2000). Natural killer/natural killer-like T-cell lymphoma (CD56+) presenting in the skin: A study of clinical and pathologic characteristics affecting survival. BLOOD, 96(11), 124A–125A.

Rituximab is active in lymphocyte predominance Hodgkin's disease.
Lucas, J. B., Hoppe, R. T., Horwitz, S. M., Breslin, S., & Horning, S. J. (2000). Rituximab is active in lymphocyte predominance Hodgkin's disease. BLOOD, 96(11), 831A.

ELECTRON-BEAM TREATMENT FOR CUTANEOUS T-CELL LYMPHOMA
JONES, G. W., HOPPE, R. T., & GLATSTEIN, E. (1995). ELECTRON-BEAM TREATMENT FOR CUTANEOUS T-CELL LYMPHOMA. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 9(5), 1057-&.

PELVIC RELAPSE FOLLOWING SUBTOTAL LYMPHOID IRRADIATION IN EARLY-STAGE HODGKINS-DISEASE - AN ANALYSIS OF RISK, MANAGEMENT, AND OUTCOME
TATE, D. J., & HOPPE, R. T. (1993). PELVIC RELAPSE FOLLOWING SUBTOTAL LYMPHOID IRRADIATION IN EARLY-STAGE HODGKINS-DISEASE - AN ANALYSIS OF RISK, MANAGEMENT, AND OUTCOME. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 27, 231.

Role of imaging in low grade cutaneous B-cell lymphoma presenting in the skin.
Kheterpal, M. K., Dai, J., Geller, S., Pulitzer, M., Ni, A., Myskowski, P. L., … Horwitz, S. M. (2019). Role of imaging in low grade cutaneous B-cell lymphoma presenting in the skin. Journal of the American Academy of Dermatology.

Larry Emanuel Kun, March 10, 1946-May 27, 2018 OBITUARY
FitzGerald, T. J., Donaldson, S. S., Wharam, M., Laurie, F., Bishop-Jodoin, M., Moni, J., … Roberts, K. B. (2019). Larry Emanuel Kun, March 10, 1946-May 27, 2018 OBITUARY. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 103(1), 8–14.

Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy
Moding, E. J., Advani, R., Rosenberg, S. A., & Hoppe, R. T. (2018). Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy. RADIOTHERAPY AND ONCOLOGY, 129(3), 507–12.

Low-dose Total Skin Electron Beam Therapy for Refractory Cutaneous CD30 Positive Lymphoproliferative Disorders.
Panjwani, N., Yoo, C. H., Wang, E., Khodadoust, M. S., Kim, Y. H., Hoppe, R. T., & Hiniker, S. M. (2019). Low-dose Total Skin Electron Beam Therapy for Refractory Cutaneous CD30 Positive Lymphoproliferative Disorders. The Journal of Dermatological Treatment, 1–5.

Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG
Binkley, M. S., Brady, J. L., Hajj, C., Chelius, M., Chau, K., Balogh, A., … Hoppe, R. T. (2019). Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 104(3), 522–29.

Volumetric Modulated Arc Therapy and 3-Dimensional Printed Bolus in the Treatment of Refractory Primary Cutaneous Gamma Delta Lymphoma of the Bilateral Legs
Obeid, J.-P., Gutkin, P. M., Lewis, J., Skinner, L., Wang, E. B., Khodadoust, M. S., … Hiniker, S. M. (2019). Volumetric Modulated Arc Therapy and 3-Dimensional Printed Bolus in the Treatment of Refractory Primary Cutaneous Gamma Delta Lymphoma of the Bilateral Legs. PRACTICAL RADIATION ONCOLOGY, 9(4), 220–25.

Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort.
Spinner, M. A., Kennedy, V. E., Tamaresis, J. S., Lavori, P. W., Arai, S., Johnston, L. J., … Lowsky, R. (2019). Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort. Blood Advances, 3(16), 2454–64.

20 Gy Versus 30 Gy: Will it Make a Difference?
Hoppe, R. T. (2019). 20 Gy Versus 30 Gy: Will it Make a Difference? International Journal of Radiation Oncology, Biology, Physics, 105(1), 102–3.

Definitive radiotherapy for localized follicular lymphoma staged by F-18-FDG PET-CT: a collaborative study by ILROG
Brady, J. L., Binkley, M. S., Hajj, C., Chelius, M., Chau, K., Balogh, A., … Mikhaeel, G. (2019). Definitive radiotherapy for localized follicular lymphoma staged by F-18-FDG PET-CT: a collaborative study by ILROG. BLOOD, 133(3), 237–45.

In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
Frank, M. J., Reagan, P. M., Bartlett, N. L., Gordon, L., Friedberg, J. W., Czerwinski, D. K., … Levy, R. (2018). In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma. CANCER DISCOVERY, 8(10), 1258–69.

Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin
Kheterpal, M. K., Dai, J., Geller, S., Pulitzer, M., Ni, A., Myskowski, P. L., … Horwitz, S. M. (2019). Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 81(4), 970–76.

Tomayto, tomahto: prescription dose and mean heart dose in evaluating the cardiac impact of involved-field radiation therapy for Hodgkin lymphoma survivors
Bates, J. E., Flampouri, S., Hoppe, R. T., Li, Z., Mendenhall, N. P., & Hoppe, B. S. (2019). Tomayto, tomahto: prescription dose and mean heart dose in evaluating the cardiac impact of involved-field radiation therapy for Hodgkin lymphoma survivors. ACTA ONCOLOGICA.

The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiotherapy Era.
Hoppe, B. S., Bates, J. E., Mendenhall, N. P., Morris, C. G., Louis, D., Ho, M. W., … Flampouri, S. (2019). The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiotherapy Era. Practical Radiation Oncology.

Tomayto, tomahto: prescription dose and mean heart dose in evaluating the cardiac impact of involved-field radiation therapy for Hodgkin lymphoma survivors.
Bates, J. E., Flampouri, S., Hoppe, R. T., Li, Z., Mendenhall, N. P., & Hoppe, B. S. (2019). Tomayto, tomahto: prescription dose and mean heart dose in evaluating the cardiac impact of involved-field radiation therapy for Hodgkin lymphoma survivors. Acta Oncologica (Stockholm, Sweden), 58(12), 1783–1785.

Keep the Dose Low. Keep the Fields Tight.
Hoppe, R. T. (2020). Keep the Dose Low. Keep the Fields Tight. International Journal of Radiation Oncology, Biology, Physics, 106(1), 15.

Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal.
Busque, S., Scandling, J. D., Lowsky, R., Shizuru, J., Jensen, K., Waters, J., … Strober, S. (2020). Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal. Science Translational Medicine, 12(528).

Long-Term Outcomes in 10-Year Survivors of Early-Stage Hodgkin Lymphoma.
Bates, J. E., Parikh, R. R., Mendenhall, N. P., Morris, C. G., Hoppe, R. T., Constine, L. S., & Hoppe, B. S. (2020). Long-Term Outcomes in 10-Year Survivors of Early-Stage Hodgkin Lymphoma. International Journal of Radiation Oncology, Biology, Physics.

Stage I-II Nodular Lymphocyte-Predominant Hodgkin Lymphoma: a Multi-institutional Experience of Adult Patients by ILROG.
Binkley, M. S., Rauf, M. S., Milgrom, S. A., Pinnix, C. C., Tsang, R. W., Dickinson, M., … Hoppe, R. T. (2020). Stage I-II Nodular Lymphocyte-Predominant Hodgkin Lymphoma: a Multi-institutional Experience of Adult Patients by ILROG. Blood.

Eli J. Glatstein: A Steward Extraordinaire of Radiation Oncology.
Coleman, C. N., Hoppe, R. T., & Metz, J. M. (2020). Eli J. Glatstein: A Steward Extraordinaire of Radiation Oncology. International Journal of Radiation Oncology, Biology, Physics, 107(1), 1–5.

Utility of Routine Surveillance Laboratory Testing in Detecting Relapse in Patients With Classic Hodgkin Lymphoma in First Remission: Results From a Large Single-Institution Study.
Lynch, R. C., Sundaram, V., Desai, M., Henry, S., Wood, D., Daadi, S., … Advani, R. (2020). Utility of Routine Surveillance Laboratory Testing in Detecting Relapse in Patients With Classic Hodgkin Lymphoma in First Remission: Results From a Large Single-Institution Study. JCO Oncology Practice, JOP1900733.

Primary Cutaneous Lymphomas Version 2.2020 Featured Updates to the NCCN Guidelines
Mehta-Shah, N., Horwitz, S. M., Ansell, S., Ai, W. Z., Barnes, J., Berta, S. K., … Kim, Y. H. (2020). Primary Cutaneous Lymphomas Version 2.2020 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 18(5), 523–36.

Long-term outcomes of patients with unfavorable stage I-II classic Hodgkin lymphoma treated with Stanford V chemotherapy and limited field irradiation.
Weil, C. R., Qian, Y., Von Eyben, R., Daadi, S. E., Corbelli, K. S., Rosenberg, S. A., … Hoppe, R. T. (2020). Long-term outcomes of patients with unfavorable stage I-II classic Hodgkin lymphoma treated with Stanford V chemotherapy and limited field irradiation. Leukemia & Lymphoma, 1–7.

Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Hoppe, R. T., Advani, R. H., Ai, W. Z., Ambinder, R. F., Armand, P., Bello, C. M., … Ogba, N. (2020). Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 18(6), 755–81.

Hodgkin lymphoma.
Connors, J. M., Cozen, W., Steidl, C., Carbone, A., Hoppe, R. T., Flechtner, H.-H., & Bartlett, N. L. (2020). Hodgkin lymphoma. Nature Reviews. Disease Primers, 6(1), 61.

A preliminary report of gonadal-sparing TBI using a VMAT technique.
Blomain, E. S., Kovalchuk, N., Neilsen, E., Skinner, L., Hoppe, R. T., & Hiniker, S. M. (2020). A preliminary report of gonadal-sparing TBI using a VMAT technique. Practical Radiation Oncology.

Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma.
Weng, W.-K. K., Arai, S., Rezvani, A., Johnston, L., Lowsky, R., Miklos, D., … Kim, Y. H. (2020). Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma. Blood Advances, 4(18), 4474–82.

NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021.
Horwitz, S. M., Ansell, S., Ai, W. Z., Barnes, J., Barta, S. K., Clemens, M. W., … Sundar, H. (2020). NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021. Journal of the National Comprehensive Cancer Network : JNCCN, 18(11), 1460–67.

Use of cardiac radiation therapy as bridging therapy to CAR-T for relapsed pediatric B-cell acute lymphoblastic leukemia.
Marquez, C. P., Montiel-Esparza, R., Hui, C., Schultz, L. M., Davis, K. L., Hoppe, R. T., … Hiniker, S. M. (2020). Use of cardiac radiation therapy as bridging therapy to CAR-T for relapsed pediatric B-cell acute lymphoblastic leukemia. Pediatric Blood & Cancer, e28870.

A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
Kumar, A., Casulo, C., Advani, R. H., Budde, L. E., Barr, P. M., Batlevi, C. L., … Moskowitz, C. H. (2019). A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma. BLOOD, 134.

Long-Term Outcomes of Patients with Early-Stage Non-Bulky Hodgkin Lymphoma Treated with Combined Modality Therapy on the Stanford V Trials (The G4 and G5 Studies).
Mou, E., Advani, R. H., von Eyben, R., Rosenberg, S. A., & Hoppe, R. T. (2020). Long-Term Outcomes of Patients with Early-Stage Non-Bulky Hodgkin Lymphoma Treated with Combined Modality Therapy on the Stanford V Trials (The G4 and G5 Studies). International Journal of Radiation Oncology, Biology, Physics.

Research-Driven Radiation Oncology: A Narrative on the Ongoing Legacy of Henry S. Kaplan
Glatstein, E. J., Coleman, C. N., Pistenmaa, D. A., Hoppe, R. T., Hahn, S., Metz, J., … Bernhard, E. (2021). Research-Driven Radiation Oncology: A Narrative on the Ongoing Legacy of Henry S. Kaplan. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 109(1), 10–14.

Stage I-II diffuse large B-cell lymphoma treated with rituximab and chemotherapy with or without radiotherapy.
Binkley, M. S., Hiniker, S. M., Younes, S., Yoo, C., Wignarajah, A., Jin, M., … Hoppe, R. T. (2021). Stage I-II diffuse large B-cell lymphoma treated with rituximab and chemotherapy with or without radiotherapy. Leukemia & Lymphoma, 1–15.

Low-Dose Total Skin Electron Beam Therapy Combined With Mogamulizumab for Refractory Mycosis Fungoides and Sezary Syndrome.
Fong, S., Hong, E. K., Khodadoust, M. S., Li, S., Hoppe, R. T., Kim, Y. H., & Hiniker, S. M. (2021). Low-Dose Total Skin Electron Beam Therapy Combined With Mogamulizumab for Refractory Mycosis Fungoides and Sezary Syndrome. Advances in Radiation Oncology, 6(3), 100629.

Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma.
Kumar, A., Casulo, C., Advani, R. H., Budde, E., Barr, P. M., Batlevi, C. L., … Moskowitz, C. H. (2021). Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2100108.

Radiation Therapy for Primary Cutaneous Gamma Delta Lymphoma Prior to Stem Cell Transplantation.
Wu, Y. F., Skinner, L., Lewis, J., Khodadoust, M. S., Kim, Y. H., Kwong, B. Y., … Hiniker, S. M. (2021). Radiation Therapy for Primary Cutaneous Gamma Delta Lymphoma Prior to Stem Cell Transplantation. Cancer Investigation, 1–11.

Technical report: 3D-printed patient-specific scalp shield for hair preservation in total skin electron beam therapy.
Rahimy, E., Skinner, L., Kim, Y. H., & Hoppe, R. T. (2021). Technical report: 3D-printed patient-specific scalp shield for hair preservation in total skin electron beam therapy. Technical Innovations & Patient Support in Radiation Oncology, 18, 12–15.

Author Correction: Hodgkin lymphoma.
Connors, J. M., Cozen, W., Steidl, C., Carbone, A., Hoppe, R. T., Flechtner, H.-H., & Bartlett, N. L. (2021). Author Correction: Hodgkin lymphoma. Nature Reviews. Disease Primers, 7(1), 79.

Primary Cutaneous Lymphoma: Recommendations for Clinical Trial Design and Staging Update from the ISCL, USCLC, and EORTC.
Olsen, E. A., Whittaker, S., Willemze, R., Pinter-Brown, L., Foss, F. M., Geskin, L. J., … Scarisbrick, J. J. (2021). Primary Cutaneous Lymphoma: Recommendations for Clinical Trial Design and Staging Update from the ISCL, USCLC, and EORTC. Blood.

The Stanford VMAT TBI Technique.
Kovalchuk, N., Simiele, E., Skinner, L., Yang, Y., Howell, N., Lewis, J., … Hiniker, S. M. (2022). The Stanford VMAT TBI Technique. Practical Radiation Oncology.

T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Horwitz, S. M., Ansell, S., Ai, W. Z., Barnes, J., Barta, S. K., Brammer, J., … Sundar, H. (2022). T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 20(3), 285–308.

Volumetric modulated arc therapy total body irradiation in pediatric and adolescent/young adult patients undergoing stem cell transplantation: Early outcomes and toxicities.
Marquez, C., Hui, C., Simiele, E., Blomain, E., Oh, J., Bertaina, A., … Hiniker, S. M. (2022). Volumetric modulated arc therapy total body irradiation in pediatric and adolescent/young adult patients undergoing stem cell transplantation: Early outcomes and toxicities. Pediatric Blood & Cancer, e29689.

NCCN Guidelines Insights: Hodgkin Lymphoma, Version 2.2022.
Hoppe, R. T., Advani, R. H., Ai, W. Z., Ambinder, R. F., Armand, P., Bello, C. M., … Sundar, H. (2022). NCCN Guidelines Insights: Hodgkin Lymphoma, Version 2.2022. Journal of the National Comprehensive Cancer Network : JNCCN, 20(4), 322–334.

In Situ Vaccination Induces Changes in Follicular Lymphoma Tumor Cells That Correlate with Abscopal Clinical Regressions
Haebe, S., Shree, T., Day, G., Sathe, A., Czerwinski, D. K., Grimes, S. M., … Levy, R. (2021). In Situ Vaccination Induces Changes in Follicular Lymphoma Tumor Cells That Correlate with Abscopal Clinical Regressions. BLOOD. AMER SOC HEMATOLOGY.

Therapeutic and Immunologic Responses Elicited By in Situ Vaccination with CpG, Ibrutinib, and Low-Dose Radiation
Shree, T., Haebe, S., Czerwinski, D. K., Day, G., Sathe, A., Khodadoust, M. S., … Levy, R. (2021). Therapeutic and Immunologic Responses Elicited By in Situ Vaccination with CpG, Ibrutinib, and Low-Dose Radiation. BLOOD. AMER SOC HEMATOLOGY.

Analysis of Metabolic Tumor Volume in Patients Undergoing Radiotherapy Prior to or After CAR-T Therapy for Relapsed/refractory Aggressive B Cell Lymphoma
Marar, M., Hiniker, S., Hoppe, R., & Binkley, M. (2022). Analysis of Metabolic Tumor Volume in Patients Undergoing Radiotherapy Prior to or After CAR-T Therapy for Relapsed/refractory Aggressive B Cell Lymphoma. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS.

Effect of Testicular Boost in Children With Leukemia Receiving Total Body Irradiation and Stem Cell Transplant: A Single-Institution Experience
Blomain, E. S., Jiang, A., Donaldson, S. S., Agarwal, R., Bertaina, A., Shyr, D., … Oh, J. (2023). Effect of Testicular Boost in Children With Leukemia Receiving Total Body Irradiation and Stem Cell Transplant: A Single-Institution Experience. ADVANCES IN RADIATION ONCOLOGY, 8(1).

Effect of Testicular Boost in Children With Leukemia Receiving Total Body Irradiation and Stem Cell Transplant: A Single-Institution Experience.
Blomain, E. S., Jiang, A., Donaldson, S. S., Agarwal, R., Bertaina, A., Shyr, D., … Oh, J. (2023). Effect of Testicular Boost in Children With Leukemia Receiving Total Body Irradiation and Stem Cell Transplant: A Single-Institution Experience. Advances in Radiation Oncology, 8(1), 101071.

Achievement of Persistent Mixed Chimerism in Recipients of Matched and Mismatched Living Donor Kidney Transplants in a Tolerance Induction Protocol
Scandling, J., Busque, S., Lowsky, R., Pham, T., Hoppe, R., Jensen, K., … Strober, S. (2022). Achievement of Persistent Mixed Chimerism in Recipients of Matched and Mismatched Living Donor Kidney Transplants in a Tolerance Induction Protocol. TRANSPLANTATION. LIPPINCOTT WILLIAMS & WILKINS.

Investigating and modeling positron emission tomography factors associated with large cell transformation from low-grade lymphomas.
Obeid, J.-P. P., Hiniker, S. M., Schroers-Martin, J., Guo, H. H., No, H. J., Moding, E. J., … Binkley, M. S. (2023). Investigating and modeling positron emission tomography factors associated with large cell transformation from low-grade lymphomas. EJHaem, 4(1), 90–99.

Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents.
Spinner, M. A., Sica, R. A., Tamaresis, J. S., Lu, Y., Chang, C., Lowsky, R., … Arai, S. (2023). Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents. Blood.

Brentuximab Vedotin Combined with Chemotherapy in Newly Diagnosed, Early-Stage, Unfavorable-Risk Hodgkin Lymphoma: Extended Follow-up with Evaluation of Baseline Metabolic Tumor Volume and PET2
Stuver, R., Michaud, L., Casulo, C., Advani, R. H., Budde, E. L., Barr, P. M., … Moskowitz, A. J. (2022). Brentuximab Vedotin Combined with Chemotherapy in Newly Diagnosed, Early-Stage, Unfavorable-Risk Hodgkin Lymphoma: Extended Follow-up with Evaluation of Baseline Metabolic Tumor Volume and PET2. BLOOD. AMER SOC HEMATOLOGY.

Activating Immune Effectors and Dampening Immune Suppressors Generates Successful Therapeutic Cancer Vaccination in Patients with Lymphoma
Shree, T., Haebe, S., Czerwinski, D. K., Eckhert, E., Day, G., Sathe, A., … Levy, R. (2022). Activating Immune Effectors and Dampening Immune Suppressors Generates Successful Therapeutic Cancer Vaccination in Patients with Lymphoma. BLOOD. AMER SOC HEMATOLOGY.

Investigating Metabolic Response after CAR-T Therapy and Bridging Radiotherapy for Relapsed/Refractory B-Cell Lymphoma
Marar, M., Hiniker, S., Hoppe, R., & Binkley, M. (2022). Investigating Metabolic Response after CAR-T Therapy and Bridging Radiotherapy for Relapsed/Refractory B-Cell Lymphoma. BLOOD. AMER SOC HEMATOLOGY.

Cutaneous Peripheral T-Cell Lymphoma Associated With a Proliferation of B Cells
Mattoch, I. W., Fulton, R., Kim, Y., Hopp, R., Warnke, R. A., & Sundram, U. N. (2009). Cutaneous Peripheral T-Cell Lymphoma Associated With a Proliferation of B Cells. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 131(6), 810–819.

Improved organ sparing using auto-planned Stanford volumetric modulated arc therapy for total body irradiation technique.
Ngo, N., Blomain, E. S., Simiele, E., Romero, I., Hoppe, R. T., Hiniker, S. M., & Kovalchuk, N. (2023). Improved organ sparing using auto-planned Stanford volumetric modulated arc therapy for total body irradiation technique. Pediatric Blood & Cancer, e30589.

Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panel.
Quaglino, P., Pimpinelli, N., Zinzani, P. L., Paulli, M., Pileri, S., Berti, E., … Barosi, G. (2023). Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panel. Hematological Oncology.

A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single cell analysis.
Shree, T., Haebe, S. E., Czerwinski, D. K., Eckhert, E., Day, G., Sathe, A., … Levy, R. (2023). A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single cell analysis. Blood Advances.

Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling.
Alig, S. K., Esfahani, M. S., Garofalo, A., Li, M. Y., Rossi, C., Flerlage, T., … Alizadeh, A. A. (2023). Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling. Nature.

Development and Validation of the Early-Stage Hodgkin Lymphoma (HL) International Prognostication Index (E-HIPI): A Report from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium
Evens, A. M., Rodday, A. M., Maurer, M. J., Advani, R. H., Andre, M., Gallamini, A., … Radford, J. (2023). Development and Validation of the Early-Stage Hodgkin Lymphoma (HL) International Prognostication Index (E-HIPI): A Report from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium. BLOOD. AMER SOC HEMATOLOGY.

Investigating the Cell States and Prognostic Impact of Tumor Microenvironment Ecosystems in Classic Hodgkin Lymphoma
Su, S., Subramanian, A., Flerlage, T., Flerlage, J. E., Alig, S. K., Moding, E. J., … Binkley, M. S. (2023). Investigating the Cell States and Prognostic Impact of Tumor Microenvironment Ecosystems in Classic Hodgkin Lymphoma. BLOOD. AMER SOC HEMATOLOGY.

International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Binkley, M. S., Flerlage, J. E., Savage, K. J., Akhtar, S., Steiner, R., Zhang, X.-Y. Y., … Hoppe, R. T. (2024). International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2301655.